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ABSTRACT
Bone loss has been identified as a characteristic response to radiation exposure in
both clinical and space settings. One of the known long-term consequences of radiation
treatment for cancer is increased risk of fracture due to declined bone health. Astronauts
are also at risk, although the sources and total doses are much different than that of
radiotherapy patients. The development of radiation protection countermeasures for longterm space missions requires a thorough understanding of the radiation’s biological effects
and the mechanisms behind them. The main objective of these studies is to further our
understanding of the effect spaceflight relevant radiation has on bone in a well
characterized animal model.
Animal models are used extensively to study the effects of radiation, with mice
being one of the most commonly used subjects. However, one consistent model does not
exist across all studies; there is considerable variation in animal strain, sex, and age. In
addition, the majority of studies examining radiation-induced bone loss have used doses
exceeding what is expected for a long-term spaceflight mission. Lower doses have been
used in some studies of heavier ions, but there is a significant lack of data for ions in the
range between carbon and iron.
The results of these studies develop a robust murine model for radiation-induced
bone loss. The model was used to confirm that spaceflight relevant doses of protons have
negative impacts on trabecular bone without regard to dose-rate and identify a novel
anabolic effect to cortical bone. Additionally, a potential differential effect of low doses of
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heavy ions based on linear energy transfer (LET) was identified. Future studies should
further investigate the mechanisms behind anabolic stimulation of osteoblasts at low doses
and evaluate its potential as a countermeasure to reductions in bone strength due to
radiation exposure. Additional data also needs to be collected to determine the full extent
of the effect of LET on bone’s response to radiation. The results will ultimately determine
if a shift in the current model of how tissues respond to heavy ion radiation is required.
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CHAPTER 1: PROJECT RATIONALE

1.1

Relevance

It has been known for decades that ionizing radiation damages bone. But in the
context of other research fields (e.g. bone marrow, genetic mutations), bone has been
categorized as a radiation insensitive tissue. Research over the last several years has
changed this view; with it now known that ionizing radiation causes a rapid loss of bone
mass at relatively low dose exposures. With this new information, this dissertation sets out
to better understand and define the parameters in which different types of radiation degrade
skeletal tissue. This research is applicable for both the clinical radiation therapy and space
exploration settings, but the doses (below 2 Gy) of whole body exposure broadly used in
the composite studies presented here are more applicable to NASA and exposure scenarios
astronauts will experience on a broad range of exploratory missions through the solar
system.

1.2

General Hypothesis

As such, the general hypothesis for this dissertation is that exposure to spaceflightrelevant radiation will negatively impact bone, but the impact will be dependent on the type
of radiation used, the total delivered dose absorbed, and the rate at which the dose is
delivered. The approach for examining this hypothesis includes: 1) Characterizing an
animal model for skeletal deterioration after irradiation to better understand which, if any,
variables control this response; 2) Determining if significant bone loss occurs following
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irradiation with protons at doses and dose rates similar to those experienced by astronauts
during a typical solar particle event; and 3) Examining if the negative effects to bone vary
for different radiation types based on the radiation’s linear energy transfer.

1.3

Specific Aims

1.3.1 Aim 1
With the goal of broadly understanding the effects of radiation on mouse bone and
of developing a broadly applicable model: Determine the structural response of trabecular
microarchitecture to radiation exposure in mice while controlling for the variables of
absorbed dose; animal age, strain, and sex; and time course early after exposure.

1.3.2 Hypothesis Aim 1
Radiation-induced bone loss is an insensitive process and mice will be resistant to
radiation-induced bone loss with one or more of these variables: age, strain or sex. Bone
loss from irradiation is not a rapid process.

1.3.3 Approach Aim 1
1. Dose Determination. 10-week-old female C57BL/6 (B6) mice were exposed to a 2,
4, or 6 Gy dose of x-rays (n = 5/group). All mice were euthanized 2 weeks after
exposure.
2. Time course. 20-week-old female B6 mice were irradiated with 2 Gy x-rays (n =
12/group) and euthanized after either 7 or 14 days.
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3. Age. Skeletally immature (9-week-old) and mature (19-week-old) female B6 mice
were irradiated with 2 Gy (n = 6/group) and euthanized after 2 weeks.
4. Strain. Female, 13-week-old B6 and DBA/2 (DBA) mice were irradiated with 2 Gy
and compared with strain-matched, non-irradiated controls (n = 6/group) 2 weeks
after irradiation.
5. Sex. 14-week-old male and female B6 mice were irradiated and compared with sexmatched, non-irradiated controls (n = 6/group).
6. Local vs. Systemic Exposure: 9-week-old female B6 mice were exposed to 0, 2, 4,
or 6 Gy of either whole body or single limb radiation (n = 6/group).

1.3.4 Aim 2
With the goal of understanding the effects of a solar particle event on bone mass:
Determine the minimum dose of proton radiation that will result in bone loss and evaluate
the trabecular microarchitectural response to exposure at low dose rates.

1.3.5 Hypothesis Aim 2
A greater degree of bone loss will result from exposure to higher doses of proton
radiation, with the threshold for structural loss being between 0.5 Gy and 1.0 Gy. Likewise,
exposure to irradiation at higher dose rates will result in more severe bone loss than lower
dose rates.

3

1.3.6 Approach Aim 2
In collaboration with the Department of Radiation Medicine at Loma Linda
University Medical Center, we irradiated groups of mice (n = 25/group) with protons. Mice
received doses of either 0.5, 0.75, 1, or 2 Gy delivered acutely (0.2-0.5 Gy/min), or 2 Gy
delivered at dose rates of either 25 cGy/hour or 50 cGy/hour. Following irradiation, all
mice were shipped to Clemson University and euthanized 2 weeks post-irradiation. Nonirradiated control mice (n = 25) were sham irradiated and killed for comparison.

1.3.7 Aim 3
With the goal of modeling exposure to GCR’s on a mission to Mars: Determine the
skeletal effects of modeled space radiation, representing a range of linear energy transfer
(LET) types of ions.

1.3.8 Hypothesis Aim 3
Mid-LET radiation, represented by

16

O and

28

Si, will cause more bone loss than

either low- or high-LET radiation (proton and 56Fe, respectively). For bone tissue, with a
relatively low cell density, the mix of particles energetic enough to kill bone cells combined
with a greater flux of ions (compared to iron) will cause more cell killing. In particular, the
death of osteocytes (a fully differentiated, non-dividing cell type) within bone tissue
initiates bone resorption.
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1.3.9 Approach Aim 3
Twenty-week-old female BALBc mice (n = 25/group) were exposed to one of four
types of radiation: 1) 150 MeV/amu protons, 2) 600 MeV/amu 16O, 3) 600 MeV/amu 28Si,
and 4) 600 MeV/amu 56Fe. Exposures were given at a dose rate of 0.5-1 Gy per minute to
total doses of 0.5 Gy for all radiation types. All mice were euthanized 14 days postirradiation. Non-irradiated controls (n = 25) were killed for comparison.
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CHAPTER 2: GENERAL BACKGROUND & LITERATURE REVIEW

2.1

Bone Biology

2.1.1 Composition of Bone
Bone is the specialized connective tissue that makes up the skeletal system. The
skeleton is composed of individual bones, which can be divided into two categories, flat
bones and long bones, based on their development. Long bones, which are used as the
classic model for bone structure, consist of a diaphysis, the central cylindrical shaft, and
two epiphyses, the wide and rounded ends, connected by a tapered region termed the
metaphysis (W. S. S. Jee 2001). The ends of the bone are generally wider than the middle
to facilitate equal distribution of load through the articular cartilage that cover the epiphysis
and metaphysis (Figure 2.1).
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Figure 2.1: Internal structure of a human long bone, with a magnified
cross-section of the interior. Reproduced from
http://www.britannica.com/EBchecked/topic/434280/osteocyte.

There are two major surfaces in bone tissue: 1) the periosteum, and 2) the
endosteum. The periosteum, located on the outer periosteal cortex, is composed of two
layers: a fibrous outer capsule and an inner cambium layer (Alexander et al. 2017). The
outer layer contains all of the blood vessels and nerves that service bone and is composed
of fibroblasts, collagen, and elastin fibers (Allen, Hock, and Burr 2004; Dempster 2006).
This includes strong collagenous fibers called Sharpeys’ fibers that allow firm attachment
between the periosteum and bone (Dempster 2006). The inner layer is positioned
immediately adjacent with the bone surface and is highly cellular (Allen, Hock, and Burr
2004). The endosteum is a thin membrane that covers the all of the inner surfaces, including
the marrow cavity, trabeculae, and blood vessel canals (Dempster 2006). While both the
periosteum and endosteum contain all of the main cell populations associated with bone
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the physical environment to which they are exposed is very different. Endosteal cells are
bathed in hematopoietic marrow while some of the periosteal surface has ligament and
tendon attachments, and fibrocartilage present. This leads to qualitative and quantitative
differences between the cells at each location, which can include differences in patterns of
growth, and response to mechanical and pharmacological stimulus (Allen, Hock, and Burr
2004).
Bone can be either lamellar or woven. Woven bone is rapidly created and is mainly
present during fracture repair and bone development. It is less organized than lamellar bone
with a random distribution of osteocytes (W. S. S. Jee 2001). Lamellar bone is composed
of lamellae (unit layers) in which all collagen fibers are oriented in approximately the same
direction. The axes of adjacent units can differ by as much as 90 degrees. This results in
orthotropic material properties, with greater stiffness and strength for tensile and
compressive loads applied through bending and axial loading.
The skeletal system is composed of two main types of bone: cortical and trabecular
(also called cancellous or spongy bone). Cortical bone accounts for about 80% of the
skeleton by mass. It is highly mineralized and forms the dense outer shell of all bones,
providing both mechanical strength and protection. The remaining 20% of bone mass
consists of trabecular bone, which also accounts for nearly 80% of total bone surface area
(Hadjidakis and Androulakis 2006). Individual trabeculae intersect to form a highly porous
lattice structure throughout flat bones and at the ends of long bones. The orientation of the
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microstructure is generally aligned so that mechanical stiffness and strength are greatest
(Keaveny et al. 2001).

2.1.2 Bone Cells
There are five main types of bone cells: osteoclasts, osteal macrophages,
osteoblasts, osteocytes, and bone-lining cells. In the adult skeleton, osteocytes are the most
numerous, making up to 95% of all bone cells (Franz-Odendaal, Hall, and Witten 2006).
By comparison, osteoblasts and osteoclasts make up only ~4-6% and ~1-2%, respectively
(Bonewald 2009). Of these, osteoblasts, osteocytes, and bone-lining cells all represent a
single cell lineage, mesenchymal stem cells, at varying stages of cellular maturity.
Osteoclasts and osteal macrophages are derived from hematopoietic precursors.
Osteoblasts derive from primitive mesenchymal cells (Mackie 2003) which also
give rise to adipocytes, myocytes, and chondrocytes (Robling, Castillo, and Turner 2006).
Mature osteoblasts are responsible for new bone formation and are found in a single layer
adjacent to the bone surface (Mackie 2003) and have a distinct cuboidal shape (Long 2011).
Mature osteoblasts can have one of three fates: embed into the bone matrix and become
osteocytes, transform into bone lining cells, or undergo apoptosis (Kular et al. 2012; FranzOdendaal, Hall, and Witten 2006). The exact proportion of osteoblasts that undergo each
of these fates is not conserved across species or even all types of bone (Franz-Odendaal,
Hall, and Witten 2006).
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Around 10-20% of osteoblasts will differentiate into osteocytes (Noble 2008).
Mature osteocytes play an important role in the support of bone structures and metabolic
functions. To this end, they express a new set of genes including DMP-1, MEPE, and SOST
(Robling, Castillo, and Turner 2006). Osteocytes remain in contact with one another and
osteoblasts on the formation surface through an extensive network of small
cytoplasmic/dendritic processes that lie in canaliculi (Noble 2008; Bonewald 2009). As
osteocytes become embedded in bone matrix, they exhibit a polarity in the direction of
process growth with the majority forming on the cell membrane facing the bone surface
(Noble 2008). These processes serve a primarily mechanosensory function by transducing
stress signals into biological activity or even apoptosis of the cell.
Bone-lining cells are terminally differentiated cells of the osteoblast lineage that
maintain the tissue formed by osteoblasts (Robling, Castillo, and Turner 2006). They cover
the bone surface where no active formation or resorption is occurring (Florencio-Silva et
al. 2015). The exact function of bone lining cells is not known, but they create an ion barrier
between the marrow cavity and the fluid in the canalicular system on the endosteal surface
(W. S. S. Jee 2001) and appear to play a role in both resorption and formation (Majeska
2001). Bone lining cells actively prevent osteoclasts from removing bone from locations
where remodeling should not occur (Florencio-Silva et al. 2015) and processes can extend
down into canaliculi where gap junctions have been observed between osteocytes and bone
lining cells (Miller et al. 1989).
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Osteal macrophages or osteomacs have been identified near the bone surface since
the 1980s (Hume, Loutit, and Gordon 1984), but were only recently characterized as a
distinct population of non-osteoclast macrophages (Chang et al. 2008). They are most
commonly found immediately adjacent to osteoblasts and, while their exact role is not
clear, their location seems to indicate they play a role in bone formation (Sinder, Pettit, and
McCauley 2015). Between 40% and 70% of osteoblasts undergo apoptosis (Lynch et al.
1998; Jilka et al. 1998) and one of the main functions of osteomacs appears to be removing
these dead cells. In addition, the phagocytosis of apoptotic osteoblasts may release factors
that promote osteoblastogenesis (Sinder, Pettit, and McCauley 2015).
Osteoclasts are the cells responsible for bone resorption and derive from a subset
of mononuclear/phagocytic cells of hematopoietic stem cell lineage. Mature osteoclasts are
giant multinucleated cells with between 4-20 nuclei (Baron 2003) that form through the
fusion of these mononuclear cells (Stenbeck 2002; Ross 2006). Prior to maturation, nonresorbing osteoclasts are located near the bone surface and are highly motile (W. S. S. Jee
2001; Stenbeck 2002). However, once osteoclasts begin actively resorbing bone, they are
normally located on the bone’s surface in resorption cavities called Howship’s lacunae (W.
S. S. Jee 2001). Mature osteoclasts dissolve mineral in acid to degrade bone (Blair et al.
2006).
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2.1.3 The Bone Remodeling Process
The remodeling process allows bone to serve its two main functions: maintaining
structural integrity and mineral homeostasis. The process involves the removal and
replacement of microscopic regions of bone in response to both mechanical and metabolic
influences (Sims and Gooi 2008). Remodeling allows bone to alter its geometry, mass, and
matrix in response to changes in loading conditions (Bouxsein 2005) and provides a
method for rapidly altering the blood concentration of the minerals (i.e. calcium and
phosphorous) it acts as a reservoir for (Burr 2002a; Bouxsein 2005; Dempster 2006). In
non-pathological cases, this amounts to 2-3% of cortical bone and 15-20% of trabecular
bone being remodeled per year (van der Linden et al. 2001; Dempster 2006).
Remodeling generally follows a resorption-formation pattern (Figure 2.2) whereby
resorption by osteoclasts is followed by new bone deposition by osteoblasts (Baron 2003;
Robling, Castillo, and Turner 2006). This system is tightly regulated to prevent either
excessive bone accumulation or loss (Eriksen, Eghbali-Fatourechi, and Khosla 2006) and
an imbalance in remodeling leads to disease conditions (osteoporosis, osteopetrosis, etc.)
based on whether osteoclast or osteoblast activity is favored (Eriksen, Eghbali-Fatourechi,
and Khosla 2006; van Bezooijen et al. 2005; Blair et al. 2006; Gass and Dawson-Hughes
2006). In the case of osteoporosis, the shift is in favor of bone resorption.
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Figure 2.2: A representation of the bone remodeling cycle. Reproduced
from http://www.umich.edu/news/Releases/2005/Feb05/bone.html.

Remodeling is achieved through the coordinated action of a cohort of cells called
the “Basic Multicellular Unit” (BMU). The BMU is made up of bone resorbing osteoclasts,
bone forming osteoblasts, osteocytes located within bone matrix, bone-lining cells
covering the bone surface. The life cycle of the BME has three phases: 1) the resorption
period, 2) the reversal period, and 3) the formation period. During the resorption phase,
osteoclasts erode bone and form a resorption cavity called a cutting cone, in cortical bone,
or Howship’s lacunae, in trabecular bone (W. S. S. Jee 2001). This is followed by the
reversal phase, the transition from osteoclast to osteoblast activity, where mononuclear
cells cover the newly resorbed surface. At least some of these cells have been shown to be
bone lining cells (Sims and Gooi 2008) and their exact function is unclear. They are thought
to complete resorption by smoothing the scalloped edges left by osteoclasts and forming a
reversal line, which modifies the bone’s surface (Robling, Castillo, and Turner 2006; Sims
and Gooi 2008). Finally, rows of osteoblasts lay down concentric layers of osteoid during
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the formation phase. This phase is the longest with the advent of primary mineralization
occurring approximately 5-10 days after osteoid is deposited and continuing until the
remodeling cavity reaches 50-60% of the maximum mineralization possible. Subsequent
secondary mineralization occurs over a period of years (Davison et al. 2006).

2.1.4 Regulation
Bone remodeling is a tightly controlled process that involves many cytokines,
hormones, and signalling pathways. While osteoclasts and osteoblasts are the main cell
types involved in the actual removal and replacement of bone tissue, the other cells of the
BMU, as well as certain immune cells, also play an important regulatory role.
The main factor controlling osteoclast activity is receptor for activation of NF-κB
(RANK) ligand (RANKL). As shown in Figure 2.3, RANKL is expressed on the surface
of osteoblasts as well as by activated T cells (Lacey et al. 1998; Hofbauer and Heufelder
2001) and binds to its receptor on the surface of osteoclasts and their precursors,
stimulating osteoclast differentiation and activation and inducing bone resorption (Lacey
et al. 1998; Suda et al. 1999; Takahashi, Udagawa, and Suda 1999; Lacey et al. 2000; Suda
et al. 2001). Osteoprotegerin (OPG), which is also secreted by osteoblasts, antagonizes
RANKL activity by acting as a soluble decoy receptor for RANKL (Simonet et al. 1997;
Kostenuik and Shalhoub 2001). The ratio of RANKL to OPG together with the level of
RANK expression on osteoclast precursors determines the transmission of the RANK
signal.
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Figure 2.3: Hormonal regulations systems on
osteoclastogenesis. PTH: Parathyroid hormone;
PTHrP: PTH related peptide; PGE2: Prostaglandin E2;
IL: Interleukin; TNF: Tumor necrosis factor; LIF:
Leukemia inhibitory factor; BMP: Bone morphogenetic
protein; TGF-: Transforming growth factor ; TPO:
Thrombopoietin; PDGF: Platelet-derived growth
factor. Reproduced from (Boyle, Simonet et al. 2003).
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Osteoblasts are activated through the binding of wnt ligand to a receptor complex
composed of frizzled receptor and LDL receptor related protein 5 (LRP5) or LRP6 coreceptor. The Wnt pathway is negatively regulated by sclerostin through competitive
binding with LRP5/6 (Li et al. 2005; Semënov, Tamai, and He 2005). Sclerostin, the
protein product of the SOST gene, is primarily secreted by osteocytes and has been found
to inhibit osteoblast proliferation and differentiation (Noble 2008; Winkler et al. 2003;
Sutherland et al. 2004; van Bezooijen et al. 2004) and stimulate osteoblast apoptosis, in
vitro (Sutherland et al. 2004). Loss of sclerostin causes sclerosteosis and Van Buchem
disease (Balemans et al. 2001; Brunkow et al. 2001) two rare bone diseases characterized
by progressive bone thickening due to increased bone formation (Figure 2.4), which leads
to generalized osteosclerosis (P. Beighton et al. 1984; Peter Beighton 1988; Hamersma,
Gardner, and Beighton 2003; Wergedal et al. 2003).
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Figure 2.4: Schematic model of sclerostin’s negative regulatory effect on bone
formation. Sclerostin produced by osteocytes may be transported through lacunae to the
bone surface where it inhibits osteoblastic bone formation. In sclerosteosis, the active
bone-forming phase of osteoblasts may be prolonged due to the absence of sclerostin and
result in an increased amount of bone formed. This will lead to an excess of bone mass
relative to normal architecture in the absence of increased bone resorption. LC, lining
cell; OB, osteoblast; OC, osteoclast; OCYT, osteocytes. Reproduced from (van
Bezooijen, Roelen et al. 2004).

Recently osteal macrophages or osteomacs have been shown to play a significant
role in maintaining bone homeostasis (Sinder, Pettit, and McCauley 2015; Batoon et al.
2017). Their exact role is not well understood, but there is mounting evidence that they
remove apoptotic osteoblasts via efferocytosis (Figure 2.5) and provide the osteoblastic
lineage trophic support during bone formation (Sinder, Pettit, and McCauley 2015). One
possible control mechanism is through nuclear factor-kappa B (NF-KB). NR-KB have a
pro-osteogenic function and direct contact between osteomacs and osteoblasts appears to
help sustain low-level NF-KB activity in osteoblasts. but they are believed to remove
apoptotic osteoblasts via efferocytosis and stimulate mineralization. In vivo, removal of
macrophages results in the loss of mature osteoblasts from remodeling sites (Chang et al.
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2008) and the complete blocking of the anabolic effects of PTH on bone formation (Cho
et al. 2014). Additionally, efferocytic macrophages can create a microenvironment
supportive of bone formation through the release of osteogenic factors like canonical Wnts
and TGF-ß (Cho et al. 2014).

Figure 2.5: A proposed working model of all the cell types involved in bone biology.
OB, osteoblast; OC, osteoclast. Reproduced from (Sinder et al. 2015).

2.2

Mechanics of Bone

The strength of a bone can be changed by altering either its structural (geometry
and microarchitecture) or tissue-level (mineral, collagen, and microdamage) material
properties (Figure 2.6) (Felsenberg and Boonen 2005; Davison et al. 2006) and a clear

18

distinction between the two is important for any discussion of bone strength. The skeletal
system is constantly undergoing tiny deformations in response to the complex distribution
of loads (or forces) generated by everyday activities. Structural properties, or structural
behaviors, describe the relationship between these deformations and applied forces in terms
of a bone’s geometry. Material properties, in contrast, reflect the intrinsic characteristics
of bone independent of geometry (Bouxsein 2005). Taken together, these define the
extrinsic properties of bone: strength, stiffness, and work (energy) to failure (Burr 2002b).

Figure 2.6: Whole bone strength is determined by the combination of its material and
structural properties. Reproduced from (Bouxsein 2005).
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2.2.1 Structural Properties - Bone Shape and Mass
Both bone size (mass) and shape (mass distribution) play an important role in the
biomechanical behavior of bone (Bouxsein 2005). Bone mass has a significant influence
on bone strength and is generally measured as bone mineral density (BMD) using dual Xray absorptiometry (DXA) (Ammann and Rizzoli 2003; Viguet-Carrin, Garnero, and
Delmas 2006). BMD is not a volumetric measurement, but instead a ratio of the mineral
content and the total area scanned (Ammann and Rizzoli 2003).
Bone is primarily loaded in bending (Rubin and Rubin 2006) and torsion (Bouxsein
2005). The shape of the bone helps resist loading, particularly bending (Forwood 2001;
Burr and Turner 2003; Bouxsein 2005). Hollow tube structure allows for increased strength
without increasing weight. Long bones are strongest in compression (Cullinane and
Einhorn 2002). Area moment of inertia (Imin, Imax) and polar moment of inertia (J) are
closely related (J = Imin + Imax) geometric terms for the distribution of mass around a neutral
axis and serve as predictors for bone resistance to bending and torsion, respectively (Burr
and Turner 2003; Rubin and Rubin 2006). For a circular bar, the area moment of inertia is
proportional to the diameter to the fourth power. Therefore, small increases in the diameter
of the bone result in marked increases in resistance to bending and torsion while
minimizing the weight of the bone (Figure 2.7).
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Figure 2.7: Three models for increasing bone strength through alteration of cortical
diameter and width. Reproduced from (Davison et al. 2006).

There are always pores present in bone in the form of vasculature, canaliculi, and
lacunae. Additional pores can be produced during remodeling and can provide locations
for crack initiation (Bouxsein 2005). Intracortical porosity, which is determined by both
the size and number of pores, accounts for approximately 50% of yield stress and 70% of
the elastic modulus (Augat and Schorlemmer 2006). This indicates that small changes in
porosity can cause a large decrease in bone strength.
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2.2.2 Structural Properties – Microarchitecture
The microarchitecture of bone is an important structural concept for both trabecular
and cortical bone. Trabecular parameters are defined in terms of orientation, thickness,
spacing, and connectivity while cortical parameters include porosity, thickness, and shape
(Felsenberg and Boonen 2005). Though beyond the scope of this dissertation, contributors
to bone strength/quality can be viewed on the ultrastructural level as well; mineral/matrix
ratios, collagen cross-linking, crystallinity (HA crystal size) and collagen fiber orientation.
The trabecular network functions to resist compressive loads and transfer these
loads across joints (Felsenberg and Boonen 2005). There is a clear loss of strength with
loss of trabecular volume (BV/TV) (Davison et al. 2006). However, other factors besides
BV/TV have an important role in determining bone strength. Trabecular thinning, loss, and
the presence of resorption pits all result in trabecular volume loss that increases the loads
of the surrounding trabecular network (van der Linden et al. 2001). As trabecular struts are
resorbed, a less connected network of trabeculae is created (Figure 2.8). Thickness
decreases, separation increases, and trabecular numbers decrease; it is the combination of
these factors that determine how loads are distributed through bone.
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Figure 2.8: Simulated images of two types of bone loss in
trabecular bone. Top right: Thinning; bottom right: Loss if
trabeculae. Reproduced from (Guo and Kim 2002).

It is suspected that isolated trabeculae fail in buckling (Bouxsein 2005). Greater
connectivity reduces unsupported length, which increases the critical buckling strength and
reduces the chance of failure. From the equation below, it can be seen that the strength (or
stress it can support) of bone is relative to the inverse of the squared length of a trabecular
strut.

𝜎=

𝜋2𝐸
𝐿 2
(2)

Where σ is the stress, E is the Young’s Modulus, and L is the length of the trabecular
strut. In this case, it can be assumed that E is constant, making strength dependent only on
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trabecular length. Because increased connectivity reduces the unsupported length of
trabecular struts (Figure 2.9), strength is increased.

Length of
Trabecular
Strut

Length of
Trabecular
Strut

Figure 2.9: Two models of trabecular architecture exhibiting how reduction in
connectivity of horizontal trabeculae will result in an increased length of
unsupported vertical struts.

Loss of connectivity has a much greater effect on trabecular strength than trabecular
thinning (Bouxsein 2005). It has been shown that a network of numerous, thin, connected
trabeculae are more biomechanically competent than disconnected, widely separated, thick
trabeculae (Weinstein and Hutson 1987). This is of particular importance due to the fact
that trabeculae are not reconnected after separation occurs. The typical compensatory
response of increasing the thickness of surrounding struts, or increased cortical thickness,
are generally not adequate to make up for the loss of strength from this discontinuity, and
the compensation is less efficient than the original structure (Silva and Gibson 1997; van
der Linden et al. 2001). Additionally, studies show that change to cancellous bone structure
is bone volume-dependent in a nonlinear manner. At low bone volume, trabecular thickness
and trabecular separation change at a much greater rate than at higher bone volume. This

24

suggests that bone becomes even more susceptible to failure when it reaches a critical point
(Parkinson and Fazzalari 2003).
Bone is in a constant state of renewal and repair. Active resorption by osteoclasts
creates 40-60 mm deep cavities in trabecular bone that, on average, are only 100 mm thick
in humans (van der Linden et al. 2001). Finite element analysis has shown that these
cavities can have a significant effect on the strength of trabeculae (Hernandez, Gupta, and
Keaveny 2006). A 20% reduction in trabecular volume will result in a greater reduction in
strength if the loss is due to resorption pits (50%) than thinning (30%) (van der Linden et
al. 2001). The increased levels of stresses and strains around resorption pits increase the
chance of failure of the trabeculae and may also stimulate excessive remodeling.

2.2.3 Material Properties – Microdamage
Bone is exposed to repeated loading during everyday activities that are well below
what is necessary to induce failure. Under normal physiological strain levels and stress
rates these cyclic loads result in microcracks (Robling, Castillo, and Turner 2006). The
resultant type of damage often depends on the loading conditions that initiated the
microcrack. Under compressive loading, microcracks are generally linear and form a crosshatched pattern, while under tensile load, microcracks are longer and more diffuse damage
is often observed (Robling, Castillo, and Turner 2006). Mechanically, a decrease in
stiffness is correlated with an accumulation of microdamage (Schaffler 2003). A stress
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fracture can result from a propagation of microcracks if the damaged tissue is not replaced
faster than new damage develops (Robling, Castillo, and Turner 2006).

2.3

General Radiation Background

2.3.1 Ionizing Radiation
There are two general forms of radiation: electromagnetic and particulate.
Particulate radiation includes electrons, α-particles, neutrons, and heavy ions (Hall and
Giaccia 2006). Neutrons are uncharged, but other forms of radiation have a negative
(electrons) or positive charge. Positively charged particles are the nuclei of atoms (e.g.,
hydrogen or iron) that have been stripped of some or all of their electrons (Attix 1986; Hall
and Giaccia 2006). In addition to the type of particle and its charge, several quantities can
be used to characterize ionizing radiation. Electromagnetic radiation sources can include
X-rays and gamma-rays, both being composed of photons consisting of zero mass and no
charge (J. E. Turner 1986; Hall 2000). X-rays are produced when electrons interact with a
target atom (specifically the electrons), emitting a portion of the kinetic energy of the
electron as a photon while ejecting an electron from its orbit. Gamma rays are produced as
the energy discharged by the decay of an unstable nucleus (J. E. Turner 1986; Hall 2000).
The wavelength of these forms of electromagnetic radiation is very short measuring an
estimated 10-8 cm.
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Ionizing radiation is radiation that has enough energy to remove electrons from
atoms as it passes through a material. Photons will ionize atoms in cells and tissue in several
ways. At lower energies, a photon can cause the ejection of a photoelectron when the
entirety of the energy is absorbed by the atom, referred to as the photoelectric effect. Other
photon interactions, namely inducing the scattering of an electron from an atom while
releasing photons of lower wavelengths (Compton effect) as well as the production of
electron pairs (electron and a positron), become more probable with increasing energy.
Charged particles move through matter in a near linear path, losing energy in small
quantities as energy is absorbed by electrons within the matter, causing direct ionization of
the atoms (Figure 2.10) (J. E. Turner 1986). The ionization density, or the number of ion
pairs that are formed along the length of the track (representing energy transfer per unit
distance), is referred to as the linear energy transfer (LET), defined in keV/µm (Hall 2000).
However, LET is not a unique descriptor because it scales with the square of particle charge
and the inverse square of particle velocity (z2/v2). Multiple combinations of z and v could
result in the same LET (Nelson 2003).

Figure 2.10: Ionization tracks for protons (right) and iron (left) radiation through
photographic emulsions. For reference, tissue cells are shown at similar magnification.
Scale: 50 µm. Reproduced from (Todd 2003).
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There are several important factors to take into account when talking about the
impact of radiation on tissue. Absorbed dose, the amount of energy absorbed per unit of
mass of material, is the most common descriptor of radiation exposure. Dose is expressed
with the SI unit of Gray (Gy), with one Gray equal to one joule per kilogram (J/kg). When
dealing with electromagnetic radiation, like x-rays, it is reasonable to assume that the dose
is distributed evenly resulting in a uniform pattern of ionization across the tissue (Nelson
2003). This assumption does not hold true with particle radiation, which has a highly
structured spatial pattern of energy absorption (Figure 2.11).

Figure 2.11: The concept of dose does not define the spatial deposition of energy per
unit mass. For low-LET (e.g. x-rays or gamma rays) the pattern is uniform, but for
high-LET it is not. Reproduced from (Nelson 2003)

In these cases, the number of particles per unit area, the particle fluence, and LET
must also be considered. Dose is then calculated from the product of fluence, F, and LET,
L, as in the following equation (Cucinotta et al. 2003).
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𝐷=𝐹 × 𝐿
It is also true that the same dose of different types of radiation can have very
different effects, depending on LET, dose rate, and number of fractions (as well as
radiosensitivity of the tissue) (Hall 2000). For instance, the same absorbed dose of heavy
ion radiation can have a much greater negative impact on tissues than that of low-LET
radiation such as photons (Hamilton et al. 2006). To help account for this difference in
types of radiation, a dose equivalent, Deq, is often used and is defined as the absorbed dose
multiplied by a weighting factor, wT.
𝐷𝑒𝑞 = 𝐷 × 𝑤𝑇
Figure 2.12 lists tissue weighting factors for various tissues as defined by the International
Committee on Radiation Protection (ICRP). The SI unit used for the equivalent dose is the
Sievert (Sv). The weighting factor for a particular type of radiation is the ratio of the
biological effects of 1 Gy dose of 250 kV X-rays on a tissue (weighting factor of 1) relative
to the biological effects of the particular radiation of interest (Hall 2000).

2.3.2 Bone Loss and Increased Fracture Risk Following Irradiation
Bone has been identified as a radiation-insensitive tissue by the ICRP (ICRP 1991)
and therefore has received less study than many other organ systems. However, atrophy is
a long-term effect following irradiation used as a single skeletal challenge, and has been
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quantified at early (1-2 weeks) (Willey et al. 2010) and late (4 month) (Hamilton et al.
2006).

Figure 2.12: Tissue weighting factor as characterized
by the International Committee on Radiation
Protection (ICRP 2001).

A preponderance of the research that has been performed has identified a reduction
in the overall number of bone-forming osteoblasts occurs following irradiation (Howland
et al. 1975; Ergün and Howland 1980; Bliss, Parsons, and Blake 1996; Hopewell 2003).
This can lead to a reduction in bone mineral density (Sams 1966; Howland et al. 1975;
Ergün and Howland 1980; Bliss, Parsons, and Blake 1996; Mitchell and Logan 1998;
Hopewell 2003). Radiation exposure decreases osteoblast proliferation while increasing
sensitivity to proapoptotic agents, elevating the likelihood of cell death (Szymczyk,
Shapiro, and Adams 2004). A greater reduction in the number and activity of osteoblasts
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relative to bone-resorbing osteoclasts results in a net loss of bone (Ergün and Howland
1980). In vitro cultures of murine osteoblasts exhibit reduced proliferation and collagen
production after low-doses of 4-6 Gy. This inhibition is attributed to a decreased growth
rate rather than to any lethal effects from the radiation (Gal et al. 2000). Osteoblast
progenitors in the marrow were found to have been largely eliminated following
irradiation, thus arresting bone formation, while resorption was maintained at the endosteal
surface (Sugimoto et al. 1991; Jacobsson et al. 1987). Trabecular bone formation within
mice tibiae ceased for 9 weeks following exposure to 20 Gy of X-rays. The reduction in
bone formation was observed concurrently with bone atrophy. Indeed, almost complete
obliteration of the metaphyseal trabecular bone was observed in growing and nearly mature
mice at 3 weeks and 5-6 weeks postirradiation, respectively. In contrast in the rabbit model,
osteocytes, which are responsible for the maintenance of mature bone, seem to be relatively
radioresistant. They remained viable for several months after single doses of 15-40 Gy
(Jacobsson et al. 1987; Sugimoto et al. 1991).
The effect of irradiation on osteoclast health and function remains unclear. Results
from studies range from decreased osteoclasts (Scheven et al. 1985), to stable numbers
(Goblirsch et al. 2005; Vit et al. 2006), to data suggesting an increase in osteoclasts
(Sawajiri, Mizoe, and Tanimoto 2003) after irradiation. However, most of these studies
observed bone atrophy as a late effect. Recent data instead suggest that osteoclast numbers
and activity increase sharply within days of exposure to radiation (Willey et al. 2008;
Kondo et al. 2009) and the majority of bone loss occurs within the first week (Willey et al.
2010).
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In humans, bone atrophy is a well-documented response to high-dose exposure to
ionizing radiation as part of cancer treatment (Howland et al. 1975; Ergün and Howland
1980; Baxter et al. 2005). The amount of bone mass lost and degree of deterioration in
bone quality depend on the total dose absorbed, the beam energy, individual fraction size,
and the age of the patient (Overgaard 1988; Mitchell and Logan 1998). Patients with
cervical cancer experienced an approximately 30% reduction in bone mineral density in
the lumbar vertebrae within 5 weeks of initiating radiation therapy. QCT analysis at 3, 6
and 12 months after therapy showed a progression in this bone loss marked by a continual
decline in vBMC (Nishiyama et al. 1992). Within one-year post-treatment osteopenia is
often reported in patients, although there is some variability in the amount of mineral lost
and the exact timing of loss of mass (Mitchell and Logan 1998; Hopewell 2003).
Bone loss during radiotherapy treatment has been associated with an increased risk
of bone fracture. Over the course of treatment patients typically experience total doses of
10-15 Gy administered as total body irradiation (TBI) or 40-70 Gy delivered locally to the
tumor. The total dose is administered in smaller daily fractions, which allows for total doses
that would be lethal if delivered all at once (Hall 2000). While the exact fractionated regime
is dependant on the type of tumor, typical fractions are between 1-2 Gy (Hall 2000).
Current methods allow for very accurate targeting of cancerous tissues, but surrounding
normal tissue still takes some portion of the treatment dose. Historically, the pelvic bones
absorb 60-70% of the total dose used in targeting anal, prostate, or gynecologic tumors
(Konski and Sowers 1996; Moreno et al. 1999) and approximately 3-6% of patients that
undergo radiotherapy will develop symptoms of a pelvic fracture. Fractures occur from
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normal loading conditions combined with reduced bone mass and elastic resistance.
Insufficiency fractures are well documented in the sacrum, sacroiliac joint, pubis, ilium,
acetabulum, and femoral neck (Overgaard 1988; Grigsby, Roberts, and Perez 1995; Bliss,
Parsons, and Blake 1996; Blomlie et al. 1996; Moreno et al. 1999; Huh et al. 2002; Ogino
et al. 2003). In 2005, a retrospective study looked at more than 6,000 women over the age
of 65 treated for cervical, rectal and anal cancers and found relative fracture risk was
increased 66%, 65% and 216%, respectively (Baxter et al. 2005). Estimates of fracture
incidence across all radiotherapy patients run as high as 34% (Abe et al. 1992).

2.4

The Space Radiation Environment

2.4.1 The Future of Spaceflight
NASA’s 2006 “Vision for Space Exploration” and 2014 “Strategic Plan” laid out
their vision for the future of space exploration including a return to the moon and human
missions to the surface of Mars (NASA 2006, 2014). These missions will have a very long
duration; with current propulsion systems, travel to Mars alone will take over 6 months
(NASA 2014). Current estimates expect the total duration for a lunar mission to be
approximately 180 days (6 months) while a Mars exploration mission will take 900-1000
days (2.5-3 years) (Cucinotta and Durante 2006). These missions are complex and present
several health challenges to the human crew: prolonged exposure to reduced gravity and
exposure to radiation.
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2.4.2 The Added Impact of Microgravity
Reduced gravity is one of the hallmarks of the space environment. Astronauts in
low-Earth orbit are essentially weightless due to their state of constant freefall and there is
very little gravity beyond Earth’s orbit. Bone loss is a known skeletal problem during
spaceflight and weightlessness and is relatively well understood (W. S. Jee et al. 1983;
Bikle and Halloran 1999; R. T. Turner 2000; T. Lang et al. 2004).
Rapid loss of bone mass and strength has been shown to occur in astronauts on the
International Space Station for durations ranging from 4.3 to 6.5 months (T. Lang et al.
2004; Keyak et al. 2009). For example volumetric bone mineral density (vBMD) of the
proximal femur exhibits a decline of 1.4% per month (T. Lang et al. 2004), which
corresponds to an 2% reduction in strength per month for a fall load (Keyak et al. 2009).
Follow-up examination 1-year after space flight revealed an incomplete recovery of vBMD
(93% of pre-flight) and bone strength indices remained 15-20% below pre-flight levels (T.
F. Lang et al. 2006).
The widely accepted ground-based model for simulated weightlessness in animals
is hindlimb suspension (HLS), which was first developed by NASA in the 1970s (Morey
et al. 1979). The model simulates the mechanical unloading and fluid shifts encountered in
space by suspending the animal by its tail at approximately a 30-degree angle from the
floor (Morey-Holton and Globus 2002).

34

2.4.3 Space Radiation
In addition to microgravity, astronauts on long-term missions will also face the
unique radiation environment of space. Solar radiation consists primarily of protons,
helium nuclei, and high energy, high charge (HZE) particles (nuclei of elements with Z>2)
from two main sources: galactic cosmic rays (GCR) and solar particle events (SPE). The
Earth is shielded from the vast majority of space radiation through the combined protective
nature of the Earth’s atmosphere and magnetosphere. Beyond low-earth orbit, where
astronauts currently spend time on the International Space Station (ISS), this protection
disappears completely. Doses are expected to be much higher on a long-term mission to
Mars than what astronauts currently receive on the ISS.

2.4.4 Solar Particle Events
There are two classes of SPE that are generated from different parts of the Sun’s
atmosphere. Impulsive events, derived from the lower solar atmosphere, are smaller and
shorter. Gradual events or coronal mass ejections (CMEs), in contrast, are larger broad
emissions of particles derived from the upper solar atmosphere and have the potential to
compromise a spaceflight crew’s health. On Earth, CME interaction with the atmosphere
are responsible for the familiar aurorae and have been associated with disruption of power
grids and damage to satellites (Nelson 2016).
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SPE are mainly composed of protons with a small amount of low-energy electrons
and heavy ions. Protons are considered the primary concern for radiation health during a
SPE due to their high energy and fluence (Benton and Benton 2001), while the electrons
and heavy ions are considered too low energy to contribute significantly to the radiation
dose (L. W. Townsend et al. 1994). As such, SPE are typically classified based on the
fluence and total energies of the protons present during an event. Events are considered
significant when fluences of protons with energies > 30 MeV exceed 109 cm-2 and reach
very large status at fluences 1010 cm-2 of protons >10 MeV (Benton and Benton 2001).
Larger SPE are less likely to occur and truly giant SPE are thought to be extremely rare
(Reedy 2006). It is important to note that SPE size is independent of elapsed time between
events (Cucinotta, Kim, and Chappell 2013) and there is historical precedent for the
occurrence of multiple large SPE within a short period of time; two such events happened
September and October of 1989 (Hu et al. 2009). SPE frequency and magnitude are heavily
influenced by the 11-year solar cycle. Between 50-75 SPE occur during a typical solar
cycle with more frequent and larger events tending to occur during solar maximum (Figure
2.13) (Benton and Benton 2001; Smart and Shea 2002). However, even with these general
trends, SPE occur essentially at random making them extremely difficult to predict
(Kronenberg and Cucinotta 2012).
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Figure 2.13: Historical data of large SPE. Reproduced from (Kronenberg and Cucinotta
2012).

There are a number of factors that will affect the total dose and dose rates generated
by SPE. These include the intensity of the disturbance on the Sun’s surface, where on the
sun the disturbance occurs relative to crew location, the state of any magnetic field between
the crew and the sun, and the amount of shielding available (National Council on Radiation
Protection and Measurements 2006). Several large SPE have been characterized in recent
years for use as references of “worst-case” scenarios, the largest of which occurred in
August 1972 (Hu et al. 2009). From this data, various models have been extensively used
to develop estimates for absorbed tissue doses from a future large SPE. These estimates
also generally account for one or more shielding parameters, the most common of which
are 1 g/cm2 (spacesuit), 5 g/cm2 (nominally shielded spacecraft), and 10 g/cm2 (storm
shelter). The skin typically experiences the highest doses while bone marrow receives
significantly less. For example, during the August 1972 SPE, estimates for delivered doses
to the skin were approximately 2.69 Gy and 32 Gy inside a spacecraft (5 g/cm2) and during
extra-vehicular activity (EVA; 0.3 g/cm2), respectively. For the blood forming organs
(BFO), dose estimates dropped to 0.46 Gy inside the spacecraft and 1.38 Gy while on EVA

37

(Hu et al. 2009). Peak dose rates inside a typical spacecraft (5 g/cm2) reached 21 and 6
cGy/hr for the skin and bone marrow, respectively. If shielding is reduced to EVA levels
(1 g/cm2 for spacesuit) peak dose rates rise sharply for skin (almost 1400 cGy/hr) and only
marginally for bone marrow (9 cGy/hr) (Parsons and Townsend 2000).
There is some concern that saturation of the satellite data during the Aug 1972 event
for spectra above 60 MeV caused spectral shape above this point to not be measured. This
would mean that the event was even more intense, and more dangerous, than previously
thought. It is also important to note that direct measurement of SPE is relatively new, with
data limited to only the last 4-5 solar cycles. Intensities vary from one solar cycle to another
and measured data may not accurately reflect typical solar activity. Ground-level
measurements taken before satellite data was available recorded higher energies and
fluences than what was reported by satellites from SPE in 1946 and 1956 (Smart and Shea
1991). In addition, based on analysis of nitrates from ice-core samples, it appears events
larger than the one recorded in Aug 1972 occurred during the 15th century (McCracken et
al. 2001).
NASA has determined the risk from SPE to be extremely small during internal
vehicle activity based on current models. Lunar, trans-lunar, and Mars EVA are scenarios
that still present significant risk to astronauts because of the reduced shielding levels
available (Kennedy 2014). Given the uncertainty in predicting SPEs and calculating the
dose it would deliver to an astronaut, a dose of approximately 1 Gy proton radiation has
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been noted as the dose for a lunar mission that should be considered for planning purposes
(Cucinotta 2006).

2.4.5 Galactic Cosmic Rays
GCR provide a constant low fluence of particles that consist of approximately 87%
protons (hydrogen ions), 12% ɑ-particles (helium ions), and 1% heavy ions (Kronenberg
and Cucinotta 2012). Heavy ions include all elements up to uranium (Benton and Benton
2001), but nuclei heavier than iron (Z > 26) are much less abundant than lighter ions
(Simpson 1983). Ion energies, E, ranging from <1 Mev/amu to >10,000 MeV/amu are
considered of main interest (Kronenberg and Cucinotta 2012). Although heavy ions only
account for a tiny percentage of the total GCR fluence, it is predicted that they contribute
around 40% of the total cumulative dose, with as much as 20% of the heavy ion
contribution coming from iron alone (Figure 2.14) (Cucinotta et al. 2003).
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Figure 2.14: Contribution to GCR by elements up to iron (Z = 26) for fluence,
dose, and dose equivalent. Reproduced from (Cucinotta et al. 2003).

GCR flux intensity varies over time and there is a distinct solar modulation for each
11-year solar cycle (Cucinotta, Kim, and Chappell 2013) with flux over two times lower at
solar minimum than at solar maximum (Figure 2.15) (Kronenberg and Cucinotta 2012).
This is due to the increased activity of the Sun at maxima. Plasma ejected during an SPE
acts as a temporary shield due to the magnetic properties inherent to plasmas and
temporarily reduces GCR intensity (Forbush 1937; Lawrence W. Townsend 2005). This
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results in a decrease in crew dose due to the lowered GCR contribution and is termed the
Forbush effect. For mission design purposes, the 1977 solar minimum is generally used as
a worst-case scenario GCR environment that an astronaut might face (National Council on
Radiation Protection and Measurements 2006).

Figure 2.15: Examples of the difference in energy spectra for four
representative ion species at solar minimum and maximum.
Reproduced from (NCRP 2006).

Estimated doses for travel outside the Earth’s magnetosphere have been calculated
to around 0.2 Gy/year based on estimated particle fluences and energy spectra. This means
that for a 1000-day exploratory mission to Mars an astronaut is expected to experience a
total accumulated dose due to GCR of 0.4-0.5 Gy (Williams et al. 1999; Cucinotta and
Durante 2006). Current models for GCR spectrum, however, appear to have uncertainties
of around 15% (National Council on Radiation Protection and Measurements 2006). In
addition, GCR particles are so penetrating that, unlike with SPE protons, shielding has little
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effect on reducing the absorbed dose (Cucinotta and Durante 2006). Hundreds of g/cm2
would be required to sufficiently reduce organ doses (Cucinotta, Kim, and Chappell 2013)
and, aside from being impractical from the perspective of spacecraft launch systems,
secondary particle generation starts to increase the dose equivalent at shielding above 20
g/cm2 (Slaba et al. 2017).

2.4.6 Response of Bone to Radiation - Spaceflight Perspective
As previously discussed, the vast majority of literature about radiation and its effect
on bone have been from the perspective of radiotherapy management. While the types of
radiation may be applicable, the doses are extremely high relative to estimates for exposure
in space. Rats exposed to carbon irradiation had a general (though non-significant) decline
in total BMD at doses of 1 and 5 Gy (Satoshi Fukuda, Iida, and Yan 2002) and significant
declines in trabecular and cortical bones at both 2.5 and 5 Gy (S. Fukuda and Iida 1999).
In response, there was a call for more research into the noncancer effects of spaceflightrelevant radiation at absorbed doses <1 Gy and at lower dose rates (National Council on
Radiation Protection and Measurements 2006).
It was only recently, that new studies began to look specifically at types and doses
of radiation relevant to spaceflight and its effect on bone. More recently, studies using mice
have shown 29-39% losses in trabecular bone in response to 2 Gy of gamma, proton,
carbon, or iron radiation (Hamilton et al. 2006). A potential LET effect was noted in a
follow-up examination of cortical bone (Lloyd et al. 2008). Lower doses have also been
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examined. Trabecular bone was negatively impacted by as little as 1 Gy or proton radiation
(Bandstra et al. 2008) and 0.47 Gy of mixed particle radiation modeling GCR caused
deterioration of trabecular and cortical bone (Bandstra et al. 2009). Altered trabecular
microarchitecture was observed after irradiation with 0.5 Gy of silicon (Macias et al. 2016).
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CHAPTER 3: CHARACTERIZATION OF A MURINE MODEL FOR RADIATIONINDUCED BONE LOSS

3.1

Introduction

Osteoporosis has been identified as a characteristic consequence of exposure to
ionizing radiation during the course of cancer treatment. Skeletal complications include
loss of bone density and increased fracture risk (Baxter et al. 2005; Hopewell 2003; Ergün
and Howland 1980). Cancer patients are treated with doses of 40-80 Gray (Gy) local to the
tumor. This is delivered in smaller fractionated doses of ~1.8 Gy given over several weeks.
For example, cervical cancer patients will receive 50-55 Gy (Huh et al. 2002) to the tumor
over a 6-week period, with each hip experiencing approximately half of this dose.
Independent of radiotherapy, hip fractures result in substantial mortality, with high
estimates of 24% mortality by one year. (Huh et al. 2002; Lane 2006). It is unlikely that
survivors will return to a pre-fracture quality of life. Bones that directly absorb radiation
during the course of radiation therapy for a tumor do have a substantially greater fracture
incidence, particularly the hip. An increased risk of hip fracture was demonstrated in
female patients treated for pelvic cancers with fracture rates increasing by 216%, 66%, and
65% for anal, cervical, and rectal cancers, respectively (Baxter et al. 2005). However, the
cellular and molecular mechanisms are poorly understood. Indeed, while fracture risk
among cancer survivors has been documented in the literature, atrophy of the irradiated
sites are less-well reported in the literature (Nishiyama et al. 1992; Howland et al. 1975).
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As long-term survivorship continues to improve, it becomes increasingly important to
understand the mechanisms for increased fracture risks from radiotherapy.
Astronauts are another population that are at risk for exposure to radiation at doses
that could potentially cause health problems. This is of particular concern during longerterm missions, such as to Mars or long stays on the International Space Station. The types
of radiation and the doses received are different from cancer therapy. Space radiation
consists mainly of protons and various heavy ions produced primarily from galactic cosmic
rays (GCRs) and solar particle events (SPEs). Galactic cosmic rays are always present at a
low dose rate and are of greater importance on Mars missions. Difficult to predict SPEs are
of primary concern on lunar missions. During a solar flare, the crew could experience doses
of up to 1 Gy over a period of hours to days (Cucinotta and Durante 2006; Cucinotta et al.
2003).
The microgravity environment of space further complicates exposure to space
radiation. Any damage radiation causes to an astronaut’s skeletal system will exacerbate
the loss caused by microgravity. Bone loss as a result of exposure to microgravity is a
known phenomenon (Vico et al. 2000; Rambaut and Johnston 1979; Lang et al. 2004).
Significant losses of cortical and trabecular bone have been observed in the femurs and
vertebrae of astronauts following 4-6 month missions on the International Space Station
(ISS) (Lang et al. 2004).
A better understanding of the mechanisms causing radiation-induced bone loss is
necessary. This necessitates the development of a consistent, defined model. Radiation-
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induced bone loss has been demonstrated in a variety of animal models of different species,
ages and strains, gender, and dose. Most research involving bone’s response to radiation
has been performed using murine models, with the most common being the C57BL/6
inbred mouse strain. We have recently identified significant loss of bone in response to
relatively low doses of radiation in a murine model (Hamilton et al. 2006; Bandstra et al.
2008). As we explore the mechanism behind this loss, it is important to fully understand
all of the parameters that control the animal model. Therefore, the purpose of this study
was to determine the functional response of radiation exposure on a murine model while
controlling for a variety of parameters including absorbed dose; animal age, strain, and sex;
and time course early after exposure.

3.2

Materials & Methods

3.2.1 Animals
All inbred strains of mice used in these studies were obtained from Taconic
(Taconic Farms, Inc., Hudson, NY) and were housed in groups of 2-3 per cage upon arrival.
Standard mice chow and water was provided ad libitum. All animals were allowed at least
a one-week acclimation period prior to the start of the study and were subsequently
sacrificed two weeks after initiation of irradiation, unless otherwise stated. All
experimental protocols were conducted with approval from the Institutional Animal Care
and Use Committee of Clemson University.
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3.2.2 Experimental design
Six separate experiments were performed. Many variables contribute to skeletal
competency and the mechanisms for radiation-induced osteoporosis are unknown.
Therefore, we evaluated the response of the following variables: absorbed dose, study
duration, age at irradiation, strain, sex, and exposure type (Table 3.1). Animals were
grouped to ensure similar mean body masses between groups at the outset of each study
(Table 3.2).
1. Dose Determination. Exposure to radiation causes animals to become sick, which
can create changes in their body weight and overall bone mass. The effects worsen
with increasing dose, so the lowest dose at which significant levels of bone loss
was observed was evaluated. 10-week-old female C57BL/6 (B6) mice were
exposed to a 2, 4, or 6 Gy dose of x-rays (n=5/group).
2. Time course. 20-week-old female B6 mice were irradiated with 2 Gy x-rays
(n=12/group) and euthanized after either 7 or 14 days.
3. Age. If irradiation occurs while the skeleton is still growing (immature), there can
be changes to the Skeletally immature (9-week-old) and mature (19-week-old)
female B6 mice were irradiated with 2 Gy (n=6/group).
4. Strain. There are known differences in the bone properties of various inbred strains
of mice. Inbred, 13-week-old B6 and DBA/2 (DBA) female mice were selected.
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Animals were irradiated with 2 Gy and compared with strain-matched, nonirradiated controls (n=6/group).
5. Sex. 14-week-old male and female B6 mice were irradiated (n=6/group).
6. Local vs. Systemic: 9-week-old female B6 mice were exposed to 0, 2, 4, or 6 Gy of
either whole body or single limb radiation.
Table 3.1. Study design specifications
Group
Size
(N)

Study
Dose
Determinant
Time Course
Age

Dose
(Gy)

Study Parameters
Study
Age at
Strain
Duration Irradiation
(Days)
(Weeks)

Sex

Exposure
Type

5

0, 2, 4, 6

14

10

BL/6

F

WB

5
6

0, 2
0, 2

7, 14
14

20
9, 19

F
F

WB
WB

Strain

6

0, 2

14

13

BL/6
BL/6
BL/6
DBA/2

F

WB

Sex

6

0, 2

14

14

BL/6

F
M

WB

Local vs.
Systemic

6

0. 2, 4, 6

14

9

BL/6

F

WB
SL

Notes. BL/6, C57BL/6 mice; F, female; M, male; WB, whole-body irradiation; SL, singlelimb irradiation

3.2.3 Radiation
Mice at Clemson University were placed under anesthesia (1.5% isoflurane) and
exposed to a single field of 140 kVp x-rays to the desired single-fraction mid-plane dose.
An industrial portable x-ray unit (Philips Medical Systems; Bothell, WA) was used to a
nominal dose rate of 1.36 Gy/min for the duration of the exposure. For whole body
exposures, up to 3 mice were exposed simultaneously. For single limb exposures, 2 mice
were placed under a lead shield (1/2” thick) such that only the distal 1/3 of the femur and
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the entire tibia were irradiated. This ensured that the pelvis and sex organs were outside
the irradiated field.
For all experiments, control animals were also anesthetized and placed inside the
inactive x-ray unit for the same amount of time as the irradiated animals, creating a sham
procedure. The irradiation served as the start of the experiment (day 0).

3.2.4

Determination of microarchitecture
Hind limbs were cleaned of nonosseous tissue and fixed in a solution of 10%

formalin. After 48 h, the left hind limbs were placed in 70% ethanol. Trabecular
microarchitecture of the left tibia was assessed using microcomputed tomography (mCT80;
Scanco Medical, Basserdorf, Switzerland) with a resolution of 15 mm (9 mm voxel size).
Scans were performed starting below growth plate and extending distally for 1 mm.
Trabecular bone volume fraction (BV/TV), connectivity density (Conn.D), trabecular
thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) were
calculated for each sample.

3.2.5 Statistical analysis
Data are presented as mean values + standard error. Statistical analyses were
performed using SigmaStat Version 3.5 (Systat Software Inc., Richmond, CA). A one-way
ANOVA was used before each study to ensure consistent starting animal masses and to
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reveal statistical differences between control and irradiated bones for the 3 doses used in
the dose determinant study. A paired t-test was used to compare right and left hindlimbs
within individual groups during the study examining local and systemic effects. All other
statistical comparisons utilized a two-way ANOVA with a Holm-Sidak post-hoc test to
determine significant effects of treatment (IR vs NR) and the factor relevant to that
particular study (1 vs 2 weeks; old vs young; B6 vs DBA). The threshold for significance
for all tests was set at a 5% probability of type I error (P=0.05).

3.3

Results

3.3.1 Dose response
Initially, we evaluated the response of bone to various doses of radiation to
determine the lowest dose necessary to achieve significant bone loss. Body mass was
similar across all doses at both the initiation and the conclusion of the study. Relative to
starting mass, non-irradiated mice were significantly larger (+5.6%) by the end of the study
(Table 3.2). Whole body exposure to 2, 4 and 6 Gy led to significantly lower BV/TV (2
Gy, -42%; 4Gy, -39%; 6Gy, -44%) for all dose groups when compared with non-irradiated
controls (Figure 3.1A). Additionally, the 2 and 6 Gy groups demonstrated an 82% and
73% decrease in Conn.D (Figure 3.1B), respectively, while Tb.N decreased by 24% and
20% in the 2 and 4 Gy groups, respectively. Changes in Tb.Sp were only significant in the
2 Gy group (+30.3%, Table 3.3). For all parameters examined there were no differences
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observed between dose groups. For all subsequent studies, a dose of 2 Gy was selected
because it was the lowest dose than produced significant changes in bone without a change
in body mass.
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Figure 3.1: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.

3.3.2 Time course: 1- versus 2-week study duration
All treatment groups had similar body masses at the start of the study (Table 3.2).
Likewise, there were no differences in final body mass. There was no significant change
in body mass in either non-irradiated or irradiated mice at either time point. At both of the
selected endpoints, there was significant decreases in BV/TV (Figure 3.2A) and Tb.N
between irradiated and non-irradiated control mice (Table 3.3). There was no difference
between timepoints. Differences in Conn.D (Figure 3.2B) and Tb.Sp were only noted in
animals sacrificed 2 weeks post-irradiation (Table 3.3).
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Figure 3.2: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.

3.3.3 Age response: actively growing versus skeletally mature
For both initial and final body masses, both groups of older mice were significantly
larger than either group of younger mice (Table 3.2). There was no difference in mass
between irradiated and non-irradiated mice of the same age for either the initial of final
time point. Final body masses were significantly larger for non-irradiated old mice (+4.1%,
P<0.005) and both non- and irradiated young mice (NI: +9.8%, P<0.005; IRR: +4.5%,
P<0.05). There were significant decreases in BV/TV, Tb.Th, and Tb.Sp between treatment
groups for both age groups (Table 3.3). However, differences between ages were not
significant. There was a noted difference in the values of BV/TV and Conn.D between the
non-irradiated animals from either age; values for younger animals were higher (Figure
3.3).
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Figure 3.3: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.

3.3.4 Strain response: C57BL/6 versus DBA
Two inbred strains of mice (C57BL/6 and DBA/2) were selected for analysis of
strain-dependent differences in bone response to radiation exposure. Starting mass was
similar for both DBA and B6 mice regardless of treatment (Table 3.2). There was a
significant difference (P<0.05) between the final masses of non-irradiated DBA and nonirradiated B6 mice. Final mass of non-irradiated B6 mice were significantly larger (+3.1%;
P<0.005) compared to starting mass, and irradiated B6 mice animals were significantly
smaller (-1.0%; P<0.05) at two weeks. Relative to starting mass, there was no significant
change in DBA mice. Non-irradiated DBA animals exhibited a much higher BV/TV and
Conn.D compared to the control B6 mice. A significant change in BV/TV (B6: -35%,
P<0.001; DBA: -29%, P<0.01) and Conn.D (B6: -52%, P<0.001; DBA: -39%, P<0.01)
was demonstrated by both strains (Figure 3.4). Changes in Tb.N, and Tb.Sp were also
observed (Table 3.3).
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Figure 3.4: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.

3.3.5 Sex response: male versus female
To evaluate the role of sex hormones in radiation-induced bone loss we exposed
both male and female mice to whole body radiation. Non-irradiated male mice had a larger
BV/TV and Conn.D. Both male and female mice demonstrated a significant decrease in
BV/TV (Male: 34.5%; Female: -27.5%; Figure 3.5A), Conn.D (Male: -52.7%; Female: 39.5%; Figure 3.5B), and Th.Sp with the values for males remaining higher than that of
the females. Male mice also experienced a significant decrease in Th.Th that was not
observed in females (Table 3.3).
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Figure 3.5: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.

3.3.6 Degree of exposure: localized versus systemic
Body masses were similar across all treatment groups at the start of the study. Final
body masses also showed no differences across groups (Table 3.2). Relative to starting
mass, only the 2 Gy SL group showed a significant decrease in body mass (-3.8%; P<0.05).
Changes in trabecular architecture were evident in the irradiated limbs, but not the nonirradiated limbs, when compared to the corresponding limb in non-irradiated controls
(Table 3.4). When compared using a paired-t test, there were significant differences in
BV/TV at all doses (Figure 3.6A). Only the 6 Gy dose resulted in no change to Conn.D
(Figure 3.6B).
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Figure 3.6: Proximal tibia BV/TV (A) and Conn.D. (B) in control (white column) and
irradiated (cross-hatched column) mice. Data presented as mean ± SEM. *p<0.001,
**p<0.01, ***p<0.05 vs. control.
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Table 3.2. Animal mass data for all studies.
Study
Dose response

Time course

Age

Strain

WB vs SL

Group
NR
2 Gy
4 Gy
6 Gy
1 week, NR
1 week, IR
2 week, NR
2 week, IR
Old, NR
Old, IR
Young, NR
Young, IR
B6, NR
B6, IR
DBA, NR
DBA, IR
NR
2 Gy, WB
2 Gy, SL
4 Gy, SL
6 Gy, SL

Initial
19.3  0.5
19.6  0.4
18.7  0.5
19.4  0.6
22.8  0.7
22.0  0.6
23.1  0.3
23.2  0.6
22.1  0.3
21.8  0.3
18.2  0.4
18.2  0.4
20.5  0.2
20.2  0.2
20.6  0.4
20.6  0.4
18.1  0.5
18.3  0.7
18.3  0.5
18.1  0.4
18.3  0.3

Final
20.4  0.5
19.6  0.5
19.3  0.5
19.8  0.5
23.9  1.2
22.2  0.5
23.6  0.5
23.9  0.9
23.0  0.4
21.8  0.2
20.0  0.4
19.0  0.5
21.1  0.3
20.0  0.3
19.5  0.3
20.3  0.3
17.8  0.2
17.5  0.3
17.5  0.4
17.3  0.5
17.7  0.2

% Ch
+5.6*
+2.5
+4.1
+4.6
+4.5
+0.7
+2.3
+2.9
+4.1**
+0.4
+9.8**
+4.5*
+3.1**
-1.0*
-5.3
-1.3
-1.6
-4.1
-3.8*
-4.0
-3.3

Notes. All values are given as mean  SEM.
* Significant difference between initial and final timepoints (P<0.05)
** Significant difference between initial and final timepoints
(P<0.005)
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Table 3.3. Trabecular bone properties quantified by microCT within the proximal tibial metaphysis from
mice receiving whole-body irradiation with x-rays.
Study

Dose response

Time course

Age

71
Strain

Sex

Group
NR
2 Gy
4 Gy
6 Gy
1 week, NR
1 week, IR
2 week, NR
2 week, IR
Old, NR
Old, IR
Young, NR
Young, IR
B6, NR
B6, IR
DBA, NR
DBA, IR
Male, NR
Male, IR
Female, NR
Female, IR

Tb.N
(mm-1)
4.41  0.08
3.34  0.23
3.53  0.17
3.75  0.15
3.07  0.32
2.68  0.13
4.41  0.08
3.34  0.23
3.15  0.26
2.72  0.38
4.14  0.14
2.86  0.32
3.78  0.05
3.10  0.12
4.96  0.09
4.38  0.15
5.10  0.09
4.44  0.15
3.52  0.11
3.06  0.20

Tb.Th
(m)
48.1  1.02
44.1  1.43
46.2  0.64
46.1  0.99
46.1  4.26
46.3  4.12
48.1  1.02
44.1  1.43
49.8  2.72
46.3  4.77
43.6  0.59
44.2  2.99
43.6  0.44
42.7  1.52
43.3  0.47
42.1  0.89
48.0  0.79
45.7  1.16
52.1  1.68
49.0  0.82

Tb.Sp
(mm)
0.226  0.006
0.294  0.015
0.285  0.017
0.264  0.015
0.331  0.041
0.374  0.022
0.226  0.006
0.294  0.015
0.319  0.027
0.376  0.051
0.238  0.010
0.358  0.045
0.262  0.004
0.325  0.012
0.196  0.004
0.228  0.008
0.183  0.003
0.220  0.007
0.278  0.008
0.323  0.018

Notes. All values are given as mean  SEM. Non-irradiated mice (NR); mice irradiated with 2 Gy (IR);
C57Bl/6 mice (B6); Old = 19-weeks at irradiation; Young = 9-weeks at irradiation; DBA/2 mice (DBA);
trabecular number (Tb.N); trabecular thickness (Tb.Th); and trabecular seperation (Tb.Sp)

Table 3.4. Trabecular bone properties quantified by microCT within the proximal tibial metaphysis from left
and right limbs of mice receiving irradiation to only a single (right) limb.
Limb

Right

Left

Group
NR
2 Gy, WB
2 Gy, SL
4 Gy, SL
6 Gy, SL
NR
2 Gy, SL
4 Gy, SL
6 Gy, SL

Tb.N
(mm-1)
3.66  0.19
2.61  0.16
2.75  0.08
2.94  0.16
2.88  0.13
3.57  0.18
3.42  0.09
3.77  0.12
3.41  0.18

Tb.Th
(m)
34.8  1.33
36.2  0.43
36.9  0.95
36.4  0.88
36.5  1.27
33.6  1.35
36.3  1.33
34.9  0.65
33.7  0.81

Tb.Sp
(mm)
0.277  0.016
0.391  0.028
0.365  0.011
0.349  0.023
0.351  0.016
0.285  0.016
0.293  0.007
0.266  0.009
0.298  0.018
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Notes. All values are given as mean  SEM. Non-irradiated mice (NR); irradiated dose delivered to the
whole-body (WB); irradiated dose delivered to the right hindlimb only (SL); trabecular number (Tb.N);
trabecular thickness (Tb.Th); and trabecular seperation (Tb.Sp)

3.4

Discussion

Radiation has long been known to damage both cancerous (rapidly dividing) cells
and normal tissue. The detrimental effects of radiation on bone health and strength have
been noted by radiation oncologists, though generally considered a consequence of slow
deterioration due to reduced bone formation (Hopewell 2003). Recent radiation studies
using rodent models have provided evidence that bone loss can be a rapid consequence of
exposure due to increased osteoclast activity, using both skeletally mature (Willey et al.
2010; Kondo et al. 2010) and young (Willey et al. 2008) C57BL/6 mice. These changes
appear to occur without a subsequent reduction in bone-formation from osteoblasts (Willey
et al. 2010).
Radiation-induced osteoporosis in rodents using both therapeutic- and spaceflightrelevant radiation types and doses persists in this same strain for months after exposure
(Hamilton et al. 2006; Bandstra et al. 2008, 2009). As such, the evidence indicating that
radiation can somehow “turn on” osteoclasts as an early response is mounting. Indeed, in
this study severe bone loss across all animal models were observed within a week or two.
But to what degree are these observations and generalizations dictated by confounding
variables inherent in the animal and radiation model, such as sex, exposure type, strain,
and age? In order to progress these studies towards generating an understanding of how
radiation therapy can cause bone loss and ultimately fractures in cancer patients, we must
try to establish a radiation-induced osteoporosis rodent model that will most appropriately
provide appropriate insight into the etiology of the condition.
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From these comparative mouse-irradiation studies, it appears that bone loss at
directly irradiated sites is largely similar to the bone loss that occurs when the whole animal
is irradiated. Bone loss within a few days occurs despite animal strain, sex, or age. Beam
energy seems to play little determinative role in the early bone loss that occurs in our rodent
model. And perhaps most intriguing, the bone loss that occurs at a dose of 2 Gy is similar
to higher doses, indicating a threshold for bone loss occurring lower than 2 Gy. In fact,
deterioration of trabecular bone has been shown with 1 Gy of gamma rays in a mouse
model (Kondo et al. 2009). Thus, mice in general seem to be robust models for studying
bone loss after exposure to radiation.
One of the main factors in determining response to radiation is the total absorbed
dose. Tissues and organs are categorized based on their relative radiosensitivity or how
susceptible they are to the harmful effects of radiation. Bone tissue is normally classified
as having low radiosensitivity with a dose curve usually greater than the 2 Gy shown here.
Total doses of 45 Gy initiated osteoradionecrosis of the jaw in monkeys (Rohrer, Kim, and
Fayos 1979) and localized doses of 50 Gy significantly reduced bending strength in rabbits
(Sugimoto et al. 1991). The findings of the dose determination portion of this paper,
however, are in agreement with multiple recent previous works showing loss of trabecular
bone at doses of 2 Gy or below (Hamilton et al. 2006; Bandstra et al. 2008, 2009; Kondo
et al. 2009; Willey et al. 2010). This increased sensitivity is possibly due to the proximity
of trabecular bone to bone marrow. The hematopoietic system (bone marrow) is highly
radiosensitive, with hematopoietic syndrome developing in humans at doses ranging from
1-6 Gy (Williams et al. 2010). Trabecular bone is completely surrounded by bone marrow
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and trabecular deterioration has been found in doses as low as 1 Gy (Bandstra et al. 2008;
Kondo et al. 2009), so trabecular bone (or rather the mechanisms inducing bone loss after
irradiation) should be considered a sensitive tissue and response.
Most documented cases of fracture are of female patients with hip fractures, but the
literature does not comment on the status of ovaries receiving radiation. In fact, many are
postmenopausal, and this deprivation of estrogen can influence bone loss. The comparison
between male and female mice in the present study was mainly designed to see how the
different sexes would respond, so testosterone and estrogen levels were not determined. It
is possible that both could have been suppressed, which perhaps could induce bone loss.
However, both male and female mice lost bone, demonstrating that the model is robust.
During cancer therapy for localized tumors such as lung or pelvic cancers, radiation
treatment is targeted to the site of the tumor and is not given over the entire body. In order
to more accurately mimic this case the animal model would need to limit the area of
exposure. We used the simplest method of exposing a single hindlimb with the entire tibia
and the distal third of femur receiving dose. This allowed us to determine if the bone loss
remained local to the area of irradiation or caused systemic bone loss through direct
comparison of irradiated and shielded (non-irradiated) limbs. This could suggest that the
differences are primarily caused by changes within the irradiated volume, and not by
systemic factors.
Total body irradiation (TBI) irradiates a number of organ and organ systems that
can influence bone homeostasis, such as the hypothalamic-pituitary axis. This can lead to

75

less growth hormone being released, which can influence IGF-1 production and has been
associated with survivors of childhood cancers having long-term reductions in BMD
(Thomas et al. 2008). Likewise, as in the previous comparison, we irradiated female
animals, which means the ovaries of TBI mice were exposed to radiation and there is the
potential for alterations in estrogen production. However, the lack of difference between
TBI and single-limb irradiation provides some evidence that changes occur within the
irradiated volume as opposed to systemically. Additionally, the ovaries in the single-limb
group were largely missed by exposure yet deterioration in trabecular bone still occurred.
This suggests that deprivation of sex hormones may not play a primary role in bone loss
after exposure.
Animal age at the point of irradiation is also a concern. C57BL/6 mice may be
considered “skeletally mature” around the ages of 16 weeks, though some growth can
continue to occur as the growth plate of long bones never fully ossifies (Ferguson et al.
2003). Irradiation damages proliferative cells, such as chondrocytes, in young growing
animals. In rodents, growth rate diminishes yet recovers following 4-5 Gy of irradiation,
with permanent effects occurring at doses greater than 12 Gy (Dawson 1968; Sams 1966).
The rate of bone growth depends on the rate of chondrocyte proliferation and the height of
the mature cell within the column. Exposure to ionizing radiation can damage these
chondrocytes, or change the columnar arrangement of the proliferative cells, thus slowing
growth (Horton et al. 2006; Sams 1966). Cartilage is an avascular tissue, relying on
diffusion of gases from nearby vasculature. Any radiation-induced change in blood supply
to the surrounding tissue can also damage cells within the growth plate. Radiation doses of
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< 1.8 Gy per fraction are typically used during cancer therapy to minimize the damage to
epiphyseal cartilage (Eifel, Donaldson, and Thomas 1995).
In C57BL/6 mice, BV/TV in the proximal tibia generally decreases with age, so
even in this case, it is unclear how suppressing bone formation would influence results.
Regardless, the degree of bone loss was similar between ages. While it is possible that the
lower amount of bone early after exposure in both groups is due to entirely different
responses (decreased growth vs. active bone loss), it seems unlikely; increased active
osteoclast numbers have been documented within days of exposure in both young (Willey
et al. 2008) and old (Kondo et al. 2009) mice of the same strain.
Selection of a model species can have a large effect on the outcome a study into
radiation responses. Different species can have very different dose minimums to activate
an effect. Healthy adult humans have an LD50/60 of approximately 4 Gy without
intervention (Lushbaugh, Fry, and Ricks 1987). For mice, the LD50/30 ranges from 6.5-9
Gy with the large variability due to differences in strain response (Williams et al. 2010).
Renal injury has been reported after doses between 4.5-6 Gy in humans (Williams et al.
2010) while a single dose of 7.2 Gy causes renal dysfunction in rats within 7 months
(Flentje et al. 1993). In comparison, mice appear to be an exception, requiring single doses
of 12 Gy or more to produce significant renal injury in less than 9 months (Stewart, Luts,
and Lebesque 1989). Other tissues also show variable response based on the mouse strain
selected.
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Incidence of osteoporosis has been associated with peak bone mass, which is
predominantly determined by individual genetics (Judex et al. 2004). It is possible that
patients with a lower bone mass may be at a higher risk for bone loss following treatment.
The two mouse strains examined were selected based on relative bone mineral density
(low: C57BL/6, high: DBA) (Beamer et al. 1996) and differences in marrow response to
ionizing radiation. DBA mice are more prone to genetic instability while C57BL/6 mice
are more resistant to instability yet more prone to cell death (Lindsay et al. 2007). It appears
that neither factor plays a significant role in mitigating radiation-induced bone loss.
However, the response of the DBA mice could prove useful for a model combining skeletal
insults, such as radiation and disuse. C57BL/6 mice are generally the mouse species used
in a disuse model because they lose a large amount of bone. However, there is so little bone
remaining that the combined effects of exposure to radiation are difficult to detect.
In conclusion, B6 mice represent a good model for determining how early bone loss
can occur after exposure to radiation. In particular, female mice may represent the more
appropriate model as hip fractures have primarily been documented in women receiving
gynecologic radiotherapy. However, if the changes are occurring primarily within the
irradiated volume, as was the case in this study, then males of multiple strains may
represent ideal models as well.
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CHAPTER 4: DOSE AND DOSE-RATE RESPONSE OF BONE ARCHITECTURAL
AND STRUCTURAL PROPERTIES IN HIND LIMBS FROM MICE EXPOSED
TO PROTON IRRADIATION

4.1

Introduction

Astronauts on long-term missions to the Moon or Mars face challenges unique to
the space environment. Bone loss from the micro- and reduced- gravity are relatively well
understood (Bikle & Halloran, 1999; Jee, Wronski, Morey, & Kimmel, 1983; T. Lang et
al., 2004; Turner, 2000). Rapid loss of bone mass and strength has been shown to occur in
astronauts on the International Space Station for durations ranging from 4.3 to 6.5 months
(Keyak, Koyama, LeBlanc, Lu, & Lang, 2009; T. Lang et al., 2004). For example
volumetric bone mineral density (vBMD) of the proximal femur exhibits a decline of 1.4%
per month (T. Lang et al., 2004), which corresponds to an 2% reduction in strength per
month for a fall load (Keyak et al., 2009). Follow-up examination 1-year after space flight
revealed an incomplete recovery of vBMD (93% of pre-flight) and bone strength indices
remained 15-20% below pre-flight levels. (T. F. Lang, Leblanc, Evans, & Lu, 2006).
Space radiation presents a significant, if less well known, risk and comes in two
forms: a relatively constant low fluence of high energy heavy ions from galactic cosmic
rays (GCRs), and infrequent bursts of high-energy protons from solar particle events
(SPEs) like solar flares. Astronauts are expected to see doses between 0.16 to 0.32 Gy or
0.4 to 1.0 Sv over the duration of a 400-day mission to a near Earth asteroid (National
Council on Radiation Protection and Measurements, 2000). Doses from a 1000-day
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mission to Mars would likely be over twice that much (Francis A. Cucinotta & Durante,
2006). A single SPE can deliver as much as a 2 Gy dose in a matter of hours (Benton &
Benton, 2001; Blakely, 2000; Stephens, Townsend, & Hoff, 2005).
We have consistently demonstrated a rapid loss of bone mass in mice exposed to
x-rays, protons and heavy ions with doses between 0.32 Gy and 2 Gy (Bandstra et al., 2008,
2009; Hamilton et al., 2006; Lloyd et al., 2012; Willey et al., 2010). Significant loss of
trabecular vBMD occurs with proton doses as low as 0.5-1 Gy (Bandstra et al., 2008;
Bowman, Livingston, Nelson, & Bateman, 2012a), and heavy ion exposure (silicon,
oxygen, iron, and mixed beam) (Bandstra et al., 2009; Bowman, Livingston, Nelson, &
Bateman, 2012b). When combined with skeletal unloading, proton exposure eliminates
most of the trabecular bone (Lloyd et al., 2012). This acute radiation-induced loss is a result
of greater osteoclast numbers as early as three days after exposure (Willey et al., 2008),
and significant bone loss occurs by seven days (Willey et al., 2010).
A single SPE can cause significant normal tissue damage at sub-lethal doses. While
rare, events like those observed in Aug 1972 and Oct 1989 could deliver radiation doses
approaching 2 Gy even behind 19 cm of aluminum shielding (5 g/cm2) (Parsons &
Townsend, 2000) and access to a storm shelter with at least 10 g/cm2 of aluminum is
required to reduce organ doses below 0.7 Gy (Townsend, Shinn, & Wilson, 1991). Even
with shielding SPEs are difficult to predict (Kronenberg & Cucinotta, 2012) and develop
rapidly leaving astronauts on extravehicular activities, like an EVA on the lunar surface,
incompletely protected.
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One limitation of previous work is that acute exposures do not model the low dose
rates of an SPE, in which the total dose is delivered over the course of hours to days. To
date, mouse experiments have only used high dose rates (acute exposure). For example,
delivering a 2 Gy dose in a matter of minutes rather than hours. Lower dose rates could
spare damage to the skeletal system. Cellular repair mechanisms begin to become a
significant factor in cell survival at dose rates below ~1 Gy/hr (Steel, Down, Peacock, &
Stephens, 1986) with sparing effects noted in low-dose-rate studies examining various
cells types (Gridley, Pecaut, Dutta-Roy, & Nelson, 2002). With this in mind, the aim of
this study is to determine if significant bone loss still occurs at mission-relevant doses
(below 1 Gy) and dose rates (25-50 cGy/hr) of protons. We examine both bone
microarchitecture and structure via microcomputed tomography (microCT) and trabecular
strength and function via finite element analysis (FEA).

4.2

Materials & Methods

4.2.1 Animals
Female C57BL/6 mice (15 weeks of age) were ordered from Taconic Farms, Inc
(Germantown, NY) and shipped directly to Loma Linda University. Mice were allowed to
acclimate at Loma Linda for one week prior to irradiation and were shipped by special
courier to Clemson University within 48 hours of exposure. Animals were group-housed
under standard procedures and maintained in a temperature-controlled and light-controlled
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room (12-hr light/dark cycle) with food and water was provided ad libitum. All protocols
were approved by the Institutional Animal Care and Use Committees at both Loma Linda
and Clemson University.

4.2.2 Irradiation
All exposures were conducted using a beam of 150 MeV protons. Four groups of
mice (n=25 mice/group) received acute whole-body irradiation to doses of 0.5 0.75, 1, or
2 Gy, with average dose rates were between 0.2 and 0.5 Gy/min. Two additional groups of
mice (n=25 mice/group) received irradiation with protons at dose rates of 25 or 50 cGy/hr
to a total dose of 2 Gy. Animals were transported in covered carts in their standard cages
from the animal care facility to the proton therapy facility. They were then placed in
ventilated plastic boxes (~ 10 x 10 x 7 cm; 2-3 mice per box) allowing the animals to move
horizontally in a single exposure plane. All boxes contained enough bedding to cover the
bottom and the mice were provided access to Napa Nectar gel as a source of food and
water. For a single exposure, boxes were stacked 4 high, 3 across, and 1 deep. During the
prolonged exposures for the 25 cGy/hour (8 hours total) and 50 cGy/hour (4 hours total)
groups, health checks were performed at intervals to ensure the animals were not distressed.
After exposure the animals were returned to their original cages and transported by
cart back to the animal care facility. Sham irradiations were conducted to simulate any
effects of restraint stress by placing control animals (n = 25) in the ventilated boxes for 4
hours before returning them to their original cages. At the earliest opportunity, mice were
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packed in shipping boxes and sent by courier to Clemson University for all biological
testing.

4.2.3 Study Endpoint
All mice were anesthetized with inhalation isoflurane (2%) and killed at the end of
the two-week experimental period. The right tibiae were removed, cleaned of all nonosseous tissues, and placed in a solution of 10% neutral buffered formalin. After 72 hours,
the tibiae were rinsed in DI water and placed in 70% ethanol for storage pending analysis.

4.2.4 Microcomputed Tomography
Sections of the proximal tibia were scanned with microcomputed tomography
(μCT80, Scanco Medical AG, Bassersdorf, Switzerland) at an isotropic voxel size of 10
μm. Scanco software (v. 6.1) was used to evaluate various markers of bone
microarchitecture. For trabecular bone, the volume of interest (VOI) began immediately
distal to the growth plate (excluding primary spongiosa) and extended 1 mm (100 slices).
Trabecular indices included: trabecular bone volume fraction (BV/TV), connectivity
density (Conn.D), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular
separation (Tb.Sp), structural model index (SMI), and trabecular volumetric bone mineral
density (vBMD). vBMD is the total mineral content divided by the total volume (TV) of
the region of interest and is a good indicator of strength in trabecular bone. BV/TV
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represents how much of TV is taken up by bone independent of mineral density. Conn.D,
Tb.Th, Tb.N, Tb.Sp, and SMI are all descriptors of trabecular characteristics and indicators
of bone quality. Tb. N measures the number of trabeculae per unit length inside the VOI.
Tb.Th and Tb.Sp are the average thickness and space between individual trabeculae,
respectively. Conn.D characterizes the degree of trabecular connectedness per unit volume
while SMI describes how rod-like (round) vs plate-like (oval) the trabecular structure is.
Analysis of cortical bone was conducted on the cortical shell adjacent to the
trabecular VOI. Examined parameters included: cortical porosity (Ct.Po), cortical
thickness (Ct.Th), volumetric bone mineral density (vBMD), tissue mineral density
(TMD), and polar moment of inertia (pMOI). Ct.Po and Ct.Th represent the number of
pores in a given cortical volume and the average cortical thickness, respectively. vBMD
and TMD are different measures of mineral content and are good indicators of bone
strength; TMD measures the total amount of mineral content in the bone while vBMD
describes the mineral density. pMOI describes a bone’s ability to resist torsion (i.e.
twisting).

4.2.5 Finite Element Analysis
Trabecular bone strength was assessed through computational finite element
analysis (FEA) using Scanco’s built-in finite element solver. A 1 mm thick cross-section
of the proximal tibia was used with an axial compression to 5% deflection (0.05 mm). The
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ability of the bone to resist displacement (stiffness, N/mm) was measured for all bones and
force to deflection (N) was calculated from stiffness*displacement.

4.2.6 Statistics
Data are presented as mean values +/- standard error (SEM). Statistical analyses
were performed using SigmaPlot 12 (Systat Software Inc., Richmond, CA). All
comparisons were made using a one-way analysis of variance (ANOVA) with a StudentNewman-Keuls post hoc test to reveal significance between groups. The threshold for
significance for all tests was set at a 5% probability of type I error (P = 0.05).

4.3

Results

4.3.1 Determination of Dose Threshold
Analysis with microCT revealed significant changes to trabecular bone within the
proximal tibia at all exposure levels. This included declines in trabecular bone volume
fraction (0.5 Gy, -12%; 0.75 Gy, -13%; 1 Gy, 17%; 2 Gy, -23%) and volumetric bone
mineral density (0.5 Gy, -9%; 0.75 Gy, -10%; 1 Gy, 15%; 2 Gy, -26%) versus control. The
2 Gy dose was also significantly lower than the 0.5 and 0.75 Gy groups for BV/TV (Figure
4.1A) and all irradiated groups for vBMD (Figure 4.1B). Trabecular connectivity, number,
and separation were also decreased at all radiation levels compared with control (Figure

89

4.1C-E) with the exception of trabecular separation at 0.5 Gy (Figure 4.1E). A difference
in SMI was only observed at the 2 Gy dose (Figure 4.1F). Trabecular thickness was the
only parameter where no difference was observed at any level of exposure (Table 4.1).
In cortical bone, exposure to lower doses resulted in mice with bones with a larger
total volume and altered cortical cross-sectional geometry relative to control (Figure 4.3
& Figure 4.4). Polar moment of inertia (pMOI), a measure of the bone’s resistance to
torsion and bending, increased by 13% (P < 0.01) and 12% (P < 0.01) in mice irradiated to
0.5 Gy and 0.75 Gy, respectively (Figure 4.3E). In addition, total volume, the volume
enclosed by the outer (periosteal) surface of the cortical wall, was 6% larger for both doses
(Figure 4.4A; P < 0.05). On the interior of the bone, the marrow cavity (medullary volume)
was significantly larger than control at 0.75 Gy (+6%, P < 0.05) but not 0.5 Gy (Figure
4.4C). The increase in total volume without a corresponding increase in the size of the
marrow cavity resulted in thickening of the cortical wall in mice exposed to 0.5 Gy (+6%,
P < 0.05; Figure 4.3C). At the 2 Gy dose, volumetric bone mineral density and tissue
mineral density decreased versus control by 2% and 3%, respectively (Table 4.1). Cortical
porosity appeared to decrease with increasing dose, but changes were non-significant
(Table 4.1).

4.3.2 Evaluation of Dose-Rate Dependence
Similar to what was shown in the dose experiment, exposure to 2 Gy of
protons caused significant negative effects to trabecular bone and there were no detectable
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differences between any of the examined dose-rates with the exception of trabecular
thickness (Table 4.2 & Figure 4.2). Significant declines in trabecular bone volume fraction
(Figure 4.2A) was indicated at all three dose-rates compared with non-irradiated controls:
acute (-23%), 50 cGy/hr (-27%), 25 cGy/hr (-22%). There was a corresponding decline in
volumetric bone mineral density (Acute, -26%; 50 cGy/hr, -30%; 25 cGy/hr, -25%; Figure
4.2B). Changes in trabecular connectivity (Acute, -42%; 50 cGy/hr, -50%; 25 cGy/hr, 41%), trabecular number (Acute, -11%; 50 cGy/hr, -11%; 25 cGy/hr, -12%), and trabecular
separation (Acute, +13%; 50 cGy/hr, +12%; 25 cGy/hr, +14%) suggest a decline in
trabecular bone quality (Figure 4.2C-E). Irradiated trabeculae also became more rounded
as indicated by the shape model index (Acute, +16%; 50 cGy/hr, +17%; 25 cGy/hr, +14%;
Figure 4.2F). There was no difference between dose rates for any parameter except
trabecular thickness. Mice exposed to 2 Gy at the lowest dose-rate (25 cGy/hr) had
significantly thicker (+5%, Table 4.2) trabeculae compared with non-irradiated controls
and mice irradiated to 2 Gy acutely or at 50 cGy/hr.
Unlike trabecular bone, analysis revealed evidence of dose-rate dependence on
effects to cortical bone (Figure 4.3 & Figure 4.4). Mice irradiated to 2 Gy with lower
dose-rates were significantly less porous (50 cGy/hr: -16%, P < 0.01; 25 cGy/hr: -14%, P
< 0.05; Figure 4.3B) than control. The -7% reduction in porosity following acute exposures
to 2 Gy remained non-significant. Lowering the dose rate also resulted in no change to
vBMD and TMD while both parameters remained declined with acute exposure (Table
4.2). Both total and medullary volume increased with decreasing dose-rate, although only
the 25 cGy/hr group was significant compared with control (Figure 4.4B & D, P < 0.05).
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4.3.3 Evaluation of Bone Strength
Bone strength was evaluated in terms of the force required to achieve a 5%
compression of a 1 mm thick section of the proximal tibia. While it did not achieve
statistical significance, there were general trends in response depending on if whole bone,
cortical bone only, or trabecular bone only were evaluated. For whole bone, the difference
versus non-irradiated bones ranged from a 3% increase at 0.5 Gy to a -2% decrease at 2 Gy
(Figure 4.5A). Force increased for all doses for the cortical component, but appeared to
increase in a dose-dependent fashion with the highest increases at 0.5 Gy (Figure 4.5C).
All dose-rates achieved similar results for both whole bone and cortical only (Figure 4.5B,
D). In trabecular bone, force was decreased overall (0.5 Gy, -14%; 0.75 Gy, -16%; 1 Gy, 26%; 2Gy, -33%) relative to control but was only significant at 2 Gy (P < 0.05; Figure
4.5E) although 1 Gy was close (P = 0.063). This decline in strength was maintained at the
2 Gy dose when dose-rate was reduced to 50 cGy/hr (-34%, P < 0.01; Figure 4.5F). When
the dose-rate was further reduced to 25 cGy/hr, the resulting 26% decline in strength
became statistically insignificant (P = 0.068; Figure 4.5F). All differences were versus
control. There were no differences between doses or dose rates.
Cortical and trabecular efficiency was also calculated. Efficiency represents the
ability of the existing bone to transfer the applied load and is calculated as stiffness (the
ability of bone to resist compression, in N/mm) per unit of bone volume (in mm3). Stiffness
for each group is shown in Table 4.3 and Table 4.4. Although no change in efficiency
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versus control was statistically significant, the bone did appear to behave differently at the
various doses and dose rates. Cortical efficiency was mostly spared at all doses (Figure
4.6A) and dose-rates (Figure 4.6B). Declines in trabecular efficiency were between 11%
and 15% for all doses and dose-rates, except for the 2 Gy dose delivered at 25 cGy/hr
(Figure 4.6C, D). In this one group, efficiency was preserved with only a 2% decline
compared with controls (Figure 4.6D).
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Figure 4.1: Indices of trabecular microarchitecture of the proximal tibiae of mice after
proton irradiation, including: (A) bone volume fraction, BV/TV, (B) volumetric bone
mineral density, vBMD, (C) connectivity density, Conn.D, (D) trabecular number, Tb.N,
(E) trabecular separation, Tb.Sp, and (F) structural model index, SMI. Values are plotted
as means ± SEM. Data were compared using a one-way ANOVA with a StudentNewman-Kuels post hoc test (α = 0.05). (*) indicates P < 0.05.
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Table 4.1. Parameters of trabecular and cortical bone architecture in the proximal tibia of mice following irradiation with
protons.
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Trabecular Parameters
BV/TV (%)
vBMD (mg/cm3)
Conn.D (1/mm3)
SMI
Tb.N (1/mm3)
Tb.Th (um)
Tb.Sp (um)
Cortical Bone
vBMD (mg/cm3)
TMD (mg)
Ct.Po (%)
Ct.Th (um)
pMOI (mm4)

0 Gy

0.5 Gy

Dose
0.75 Gy

1 Gy

2 Gy

6.57 ± 0.17
93 ± 2
55.8 ± 4.7
2.24 ± 0.05
3.26 ± 0.05
39.3 ± 0.4
312 ± 5

5.81 ± 0.22*a
84 ± 3*a
45.1 ± 2.9*
2.36 ± 0.06a
3.08 ± 0.07*
39.1 ± 0.6
331 ± 8

5.69 ± 0.19*b
84 ± 3*b
41.0 ± 3.4*
2.39 ± 0.05b
3.02 ± 0.07*
39.6 ± 0.6
339 ± 9*

5.42 ± 0.15*
79 ± 2*c
41.5 ± 2.6*
2.40 ± 0.04c
2.91 ± 0.06*
39.0 ± 0.5
350 ± 8*

5.05 ± 0.20*ab
69 ± 3*abc
32.6 ± 3.3*
2.61 ± 0.06*abc
2.90 ± 0.06*
39.6 ± 0.7
352 ± 8*

872 ± 5
1013 ± 4
8.8 ± 0.4
174 ± 2
0.742 ± 0.015

872 ± 3
1018 ± 4a
8.9 ± 0.2
184 ± 2*abc
0.838 ± 0.018*a

873 ± 3a
1016 ± 3b
8.7 ± 0.3
175 ± 2a
0.830 ± 0.020*b

866 ± 4b
1005 ± 5c
8.3 ± 0.2
174 ± 3b
0.789 ± 0.016

856 ± 5*ab
986 ± 7*abc
8.2 ± 0.3
173 ± 2c
0.743 ± 0.017ab

Notes. BV/TV, trabecular volume fraction; Conn.D, connectivity density; SMI, structural model index; Tb.N,
trabecular number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; vBMD, volumetric bone mineral density;
TMD, tissue mineral density; Ct.Po, cortical porosity; Ct.Th, cortical thickness; Ct.V, cortical volume; pMOI, polar
moment of inertia. Data are reported as means ± SE. Statistics performed using one-way ANOVA with Student-NewmanKeuls post hoc tests. * P < 0.05 versus control; a-d Significant difference between groups with corresponding letters (P <
0.05).
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Figure 4.2: Indices of trabecular microarchitecture of the proximal tibiae of mice after
proton irradiation to a 2 Gy total dose, including: (A) bone volume fraction, BV/TV, (B)
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Table 4.2. Parameters of trabecular and cortical bone architecture in the proximal tibia of mice following
irradiation with protons to a 2 Gy total dose and evaluating the effect of different dose rates.
Dose Rate
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Trabecular Parameters
vBMD (mg/cm3)
BV/TV (%)
Conn.D (1/mm3)
SMI
Tb.N (1/mm3)
Tb.Th (um)
Tb.Sp (um)
Cortical Parameters
vBMD (mg/cm3)
TMD (mg)
Ct.Po (%)
Ct.Th (um)
pMOI (mm4)

NR

25 cGy/hr

50 cGy/hr

Acute

93 ± 2
6.57 ± 0.17
55.8 ± 4.7
2.24 ± 0.05
3.26 ± 0.05
39.3 ± 0.4
312 ± 5

69 ± 3*
5.10 ± 0.19*
33.1 ± 3.0*
2.57 ± 0.05*
2.86 ± 0.06*
41.2 ± 0.6*ab
355 ± 8*

65 ± 2*
4.8 ± 0.2*
28.2 ± 2.0*
2.63 ± 0.04*
2.90 ± 0.06*
39.1 ± 0.5a
350 ± 8*

69 ± 3*
5.05 ± 0.20*
32.6 ± 3.3*
2.61 ± 0.06*
2.90 ± 0.06*
39.6 ± 0.7b
352 ± 8*

872 ± 5
1013 ± 4
8.8 ± 0.4*
174 ± 2
0.742 ± 0.015

870 ± 4a
997 ± 6
7.6 ± 0.3*
167 ± 2
0.780 ± 0.024

879 ± 4b
1007 ± 5a
7.4 ± 0.3
174 ± 2
0.781 ± 0.015

856 ± 5*ab
986 ± 7*a
8.2 ± 0.3
173 ± 2
0.743 ± 0.017

Notes. All exposures except control were to a 2 Gy total dose. NR, Non-Irradiated Control (0 Gy); BV/TV,
trabecular volume fraction; Conn.D, connectivity density; SMI, structural model index; Tb.N, trabecular
number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; vBMD, volumetric bone mineral density;
TMD, tissue mineral density. Data are reported as means ± SE. Statistics performed using one-way ANOVA
with Student-Newman-Keuls post hoc tests. * P < 0.05 versus control; a-b Significant difference between groups
with corresponding letters (P < 0.05).
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Figure 4.3: Indices of cortical bone in the proximal tibiae of mice after proton
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Figure 4.4: Indices of cortical bone in the proximal tibiae of mice after proton
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Figure 4.6: Efficiency of (A-B) cortical and (C-D) trabecular bone in response to axial
loading was calculated as bone stiffness (N/mm) per unit of bone volume (mm3). Values
are plotted as means ± SEM. Data were compared using a one-way ANOVA with a
Student-Newman-Kuels post hoc test (α = 0.05). (*) indicates P < 0.05

101

Table 4.3. Mechanical properties the proximal tibia to axial compression following irradiation with protons.
Dose
(Gy)
0
0.5
0.75
1
2

Total Bone
Stiffness
% Diff
(N/mm)
6723 ± 94
6907 ± 87
+2.7%
6738 ± 111
+0.2%
6725 ± 116
NC
6585 ± 91
-2.0%

CORT Only
Stiffness
% Diff
(N/mm)
5993 ± 119
6280 ± 83
+4.8%
6126 ± 110
+2.2%
6183 ± 135
+3.2%
6094 ± 105
+1.7%

TRAB Only
Stiffness
% Diff
(N/mm)
729 ± 52
627 ± 44
-14.0%
612 ± 54
-16.1%
542 ± 51+
-25.7%+
491 ± 51*
-32.7%*
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Notes. CORT = cortical bone only; TRAB = trabecular bone only. Acute doses were delivered at average
dose rates between 0.2 and 0.5 Gy/min. Stiffness represents the bone’s ability to resist deflection (0.01 mm in
this case). %Diff is the percent change in stiffness versus non-irradiated control (0 Gy group). Data reported as
means ± SE. * P < 0.05 versus control. + P = 0.063.

Table 4.4. Mechanical properties the proximal tibia to axial compression following irradiation with protons to
a 2 Gy total dose and evaluating the effect of different dose rates.

Dose Rate
NR
Acute
50 cGy/hr
25 cGy/hr

Total Bone
Stiffness
% Diff
(N/mm)
6723 ± 94
6585 ± 91
-2.0%
6682 ± 99
-0.6%
6572 ± 119
-2.2%

CORT Only
Stiffness
% Diff
(N/mm)
5993 ± 119
6094 ± 105
+1.7%
6199 ± 110
+3.4%
5966 ± 120
-0.5%

TRAB Only
Stiffness
% Diff
(N/mm)
729 ± 52
491 ± 51*
-32.7%*
*
483 ± 29
-33.8%*
#
606 ± 54
-16.9%#
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Notes. All exposures except control were to a 2 Gy total dose. CORT, cortical bone only; TRAB, trabecular
bone only; NR, Non-irradiated controls (0 Gy). Stiffness represents the bone’s ability to resist deflection (0.01
mm in this case). %Diff is the percent change in stiffness versus non-irradiated control (0 Gy group). Data
reported as means ± SE. * P < 0.05 versus control. # P = 0.068.

4.4

Discussion

Mature bone tissue has long been considered a relatively radioresistant tissue in
spite of the fact that bone loss is a known consequence of exposure to ionizing radiation.
We previously proposed a dose threshold for skeletal deterioration in response to proton
radiation of between 0.5 and 1 Gy (Bandstra et al., 2008) and have repeatedly demonstrated
that bone loss is specific to trabecular bone across multiple types of radiation at moderate
doses (1-2 Gy) (Bandstra et al., 2008; Hamilton et al., 2006; Willey et al., 2010). Data in
the present study suggest that not only is the threshold for proton irradiation lower than 1
Gy, but that a single acute exposure to 0.5 Gy stimulates an unexpected anabolic response
on the periosteal surface.
Ionizing radiation has been well established as damaging to cells, with the potential
to cause DNA strand breaks that can lead to apoptosis or cancer-causing transformations.
However, although it remains controversial, there have been numerous studies that show
beneficial (hormetic) effects in response to low-dose radiation, including enhanced DNA
repair, antioxidant capacity, and cellular metabolic activity (Li, Wang, Cui, Xue, & Cai,
2004). In mice, as little as 4.4 cGy of iron ions caused long term increases in trabecular
bone (Karim & Judex, 2014). Stimulation of bone marrow hematopoietic progenitor cells
occurs with 75 cGy of radiation (Li et al., 2004). However, to the best of the authors’
knowledge, this is the first time it has been demonstrated in bone in response to low dose
protons.

104

Several cortical indices we evaluated provide evidence for formation to the
periosteal surface. First, the cortical wall of mice exposed to 0.5 Gy of protons was much
thicker than both control animals and those irradiated to any other dose. This proves that
new bone is being formed, but did not tell us where it is happening. For that we needed to
look for changes in the size of the medullary (marrow) space and the overall bone. Analysis
showed that bones of the lowest dose group were enlarged but had similarly sized marrow
cavities compared with controls, which suggests that growth is happening outwards from
the periosteal surface. Periosteal growth was high enough to also alter the bone’s polar
moment of inertia. Polar moment of inertia (pMOI or J) represents the ability of the bone
to resist torsion and is calculated as
J = Imax + Imin
Imax and Imin are the maximal and minimal axes where the greatest and least distributions
of mass are located, respectively. pMOI was larger in mice exposed to low dose protons
making the bone more resistant to torsional loads and could also indicate that the bone was
expanding in response to changing loading conditions caused by destruction of the
trabecular network.
Consistent with our previous findings for mice exposed to protons there was
significant deterioration to trabecular bone in the 1 and 2 Gy groups (Bandstra et al., 2008).
However, in contrast with the previous study, we also demonstrated significant effects at
doses below 1 Gy. The degree to which bone declined was dose-dependent and for most
parameters appeared fairly linear. There was minimal evidence of a modulating effect of
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dose-rate on the consequences of exposure to bone with the exception of some cortical
parameters at the lowest dose rate we examined (25 cGy/hr). If anything, the observed
changes and were similar to those seen in mice acutely exposed to lower total doses. This
was surprising because there are well known dose-rate effects for both gamma and x-rays.
There has been some question about how well acute exposures represent the actual
conditions of SPE, but we have provided evidence that dose-rate does not spare bone from
the negative effects of irradiation. Additional studies are required to determine if this holds
true at doses below 2 Gy where damage to the bone is not as severe and there is the potential
for recovery.
An important consideration when comparing the two studies is the difference in
study duration: 4 months in the older study versus 2 weeks for the present study. It is now
known that skeletal deterioration occurs soon after exposure and not as a late effect as
originally thought (Willey et al., 2010). In addition, the mice used previously were young
(2 months old) at irradiation. Mice are not considered skeletally mature until around 16
weeks of age. This means that during the time when the most dramatic effects of bone loss
should have been occurring, the mice were still actively growing. Radiation did not appear
to negatively affect growth rates and, by the end of the study (4 months after irradiation),
bone turnover appears to have stabilized (Bandstra et al., 2008).
Under normal conditions bone homeostasis is maintained through the coordinated
actions of bone forming osteoblasts and bone resorbing osteoclasts. Imbalances on either
side have been linked to various bone diseases like osteoporosis. Enhanced osteoclast
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activity has been repeatedly demonstrated with exposure to various types of radiation
(Kondo et al., 2009; Willey et al., 2008). We have previously demonstrated that within 24
hours of exposure to X-rays, there is a detectable elevation in tartrate-resistant acid
phosphatase (TRAP-5b), a serum marker for osteoclast activity (Willey, Lloyd, Nelson, &
Bateman, 2011), with a subsequent increase in osteoclast number after 3 days (Willey et
al., 2008) and loss of trabecular bone within 1 week (Willey et al., 2010). That this occurs
without a corresponding increase in osteoblast activity indicates there is an “un-coupling”
of the resorption-formation paradigm in favor of resorption and rapidly results in a loss of
bone tissue. However, while osteoclast activation is rapid, it is also transient. Elevated
osteoclast numbers persist through 10 days after exposure (Kondo et al., 2009) but not 14
days (Willey et al., 2010). The effect this has on bone mass has been demonstrated in the
data. Trabecular bone volume fraction (%BV/TV) continues to decline through 3 weeks
after exposure, but the vast majority of the loss occurs within the first week (Willey et al.,
2010).
One of the keys to bone’s response to radiation is probably its direct proximity to
bone marrow, one of the most radiosensitive tissues in the body. Radiation exposure is
known to cause a rapid depletion of bone marrow cells in a dose-dependent fashion. Less
than 1 Gy is required to induce mitotic death of bone marrow stem cells in mice (Dainiak,
2002). Treatments of cancers and hematological disorders routinely ablate the marrow with
8-12 Gy of total body irradiation prior to bone marrow transplant (Deeg & Sandmaier,
2010; Inagaki et al., 2011). However, changes to bone following sub-lethal irradiation do
not appear to be linked to the state of marrow cell populations, which include both
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osteoclast and osteoblast precursors (Green, Adler, Chan, & Rubin, 2012). Instead, we have
previously proposed radiation-initiated inflammation as the mechanism behind radiationinduced bone loss (Willey et al., 2011) and it is possible that the source of the inflammation
is the damaged marrow cells.
Macrophages are specialized phagocytes responsible for removing apoptotic cells
and removing cellular debris. They also play a key role in regulating inflammation through
the secretion of cytokines. There are three main subtypes of macrophages based on their
primary function: classically activated (immune response) macrophages (M1), woundhealing macrophages (M2), and regulatory macrophages which include most tumorassociated macrophages (TAM) (Mosser & Edwards, 2008). Low- to moderate dose
radiation (<1.0 Gy) is known to modulate macrophage activity in treatment of
inflammatory disease (Wunderlich et al., 2015) and following marrow ablation there is a
marked increase in macrophage activity in the marrow cavity. Increased macrophage
activity has been linked to bone loss. Wear-induced osteolysis develops when wear
particles, liberated from an implant, stimulate a chronic inflammatory response that is
dominated by macrophages (Amstutz, Campbell, Kossovsky, & Clarke, 1992). These
macrophages then release pro-inflammatory factors like TNFα and RANKL which
stimulate osteoclast formation and activity and ultimately leads to loss of bone (Holding et
al., 2006).
Increased macrophage activity could also potentially explain the periosteal
formation we are currently reporting. Osteal macrophages have recently been characterized
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as a distinct population of non-osteoclast macrophages (Chang et al., 2008). They are most
commonly found immediately adjacent to osteoblasts and, while their exact role is not
clear, their location seems to indicate they play a role in bone formation (Sinder, Pettit, &
McCauley, 2015). Recent data with low doses of x-rays have shown that while osteoblast
progenitors are wiped out early after exposure (Lima et al., 2017), the survival of mature
osteoblasts is enhanced with promotion of mid- to late-stage differentiation (Chen, Dong,
Huang, She, & Xu, 2017). Combined with elevated levels of formation promoting factors,
like canonical Wnts and TGF-ß, from increased osteal macrophage activity (Cho et al.,
2014), a microenvironment favorable to bone formation could result. The exact mechanism
by which osteomac differentiation and activation occurs is largely unknown, but both
osteoclasts and osteomacs come from the same pool of myeloid precursors (Sinder et al.,
2015). Further research would be necessary to determine if there is a similar increase in
osteomac activity and what role it would play in regulating the response of osteoblasts.
With increasing dose there was less bone making up fewer trabeculae, with
increased spacing between trabeculae, and with less connections to other trabeculae. All of
these parameters are important to the overall strength of the trabecular network. BV/TV
and vBMD indicate “how much” bone is present in two different ways. BV/TV represents
what percentage of the total volume is made up of bone tissue while vBMD is simply a
measure to the total mineral content present. In both cases higher values, or “more bone”
would correspond to higher bone strength. Conn.D is a measure of how interconnected the
trabeculae are with more connections allowing for better load transfer and higher strength.
SMI estimates the trabecular shape with values of 0 for a perfect plate (elongated oval
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cross-section) and 3 for a perfect rod (circular cross-section). Plate-like trabeculae are
better able to resist bending. Tb.N, Tb.Th, and Tb.Sp are also trabecular descriptors,
describing the average number of trabeculae per unit length, the average trabecular
thickness, and the average distance between trabeculae, respectively. Decreasing the
number or thickness of trabecula or increasing separation all negatively impact strength.
Trabecular strength also appeared to decrease in a fairly linear fashion with
increasing dose, although only the 2 Gy dose was statistically significant, and corresponds
well with the observed declines in trabecular microarchitecture. The fact that as little as 0.5
Gy of protons resulted in a 14% reduction strength could still indicate the potential for
problems. Although lower doses (0.5 and 0.75 Gy) lost less trabecular bone overall and are
stronger than higher doses (1 and 2 Gy), all doses had similar trabecular efficiency.
Efficiency represents the bone’s ability to resist compression (its strength) per unit of bone
volume available. This means that although the 0.5 Gy group had more bone, it was not
contributing as much value to the overall trabecular strength as the lower amount of bone
in the 2 Gy group. In addition, while the periosteal formation observed in the lowest dose
group did appear to have a subtle benefit to cortical strength, improving resistance to
compression by 5% versus control, the bone was not any more efficient than at any other
dose. The new bone is most likely highly disorganized with low mineralization.
Histological evaluation would be needed to confirm these suspicions. It is also interesting
that both strength and efficiency were preserved in trabecular bone at the lowest dose-rate
examined. This was despite similar trabecular deterioration to higher rates of exposure.
The slower accumulation of cellular damage experienced at lower dose rates may allow
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time for some repair mechanisms to kick in and allow more selective removal of “less
necessary” trabecular bone. A limitation of this analysis is that bone parameters were only
evaluated at one location- the proximal tibia. In future studies, inclusion of the femur middiaphysis, which has nominal trabecular bone, and the neck of the femur, where the
majority of osteoporotic bone breaks occur, would allow for a clearer picture of corticalspecific changes and a more relevant evaluation of changes in bone strength.
Skeletal fracture is a late effect of exposure to radiation that has been repeatedly
documented in cancer patients undergoing radiation treatment (Baxter, Habermann,
Tepper, Durham, & Virnig, 2005; Bliss, Parsons, & Blake, 1996; Grigsby, Roberts, &
Perez, 1995; Huh et al., 2002; Ogino, Okamoto, Ono, Kitamura, & Nakayama, 2003;
Overgaard, 1988; Pierce et al., 1992; Webster, Thompson, Morgan, Grisby, & Dasgupta,
2001). Fracture incidence is thought to correspond with skeletal deterioration and a
corresponding decrease in bone strength. Significant losses in strength at multiple different
sites have been identified in various animal models after exposure (Nyaruba, Yamamoto,
Kimura, & Morita, 1998; Sugimoto et al., 1991; Wernle, Damron, Allen, & Mann, 2010)
although they tend to use much higher clinical-relevant doses. Prolonged exposure to
microgravity is also known to cause decreased strength due to bone atrophy and several
studies have examined the combined effect of unloading and radiation. Any bone fracture
in a crew member is potentially mission ending and, depending on location and severity,
potentially life threatening as well.
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Various possible countermeasures have been considered for prevention of bone loss
in astronauts, one of which is the administration of bisphosphonates, a class of drugs
currently used to treat osteoporosis. In mice, the bisphosphonate risedronate was shown to
successfully prevent trabecular deterioration after exposure to x-rays (Willey et al., 2010).
Similarly, treatment with the bisphosphonate alendronate prevented skeletal deterioration
due to microgravity in astronauts during missions to the International Space Station.
However, not all astronauts (20%) were able to complete the full protocol due to
intolerance to the drug (Leblanc et al., 2013) and incomplete compliance with dosing
schedules on a future Mars mission could leave astronauts vulnerable. The effects of
shielding have also been considered. NASA has generally placed a low emphasis on the
effects of SPE because fewer than 5% of SPE are expected to generate total doses that pose
a significant risk to unshielded crew members and localized shielding strategies are
considered sufficient for mitigating exposure during the few hours when exposure rates are
at their peak. However, prediction models are not currently adequate to determine when an
SPE will begin or how large the event will be (F. A. Cucinotta & Kim, 2012), and over the
prolonged duration of future missions it is likely that astronauts will eventually experience
a large SPE while on an EVA without access to a suitable shelter. Exposure limits for space
crews are published by the NCRP in the US and their recommendations are based on a 3%
excess lifetime risk of fatal cancer (National Council on Radiation Protection and
Measurements, 2000). Other late effects like cataracts (F. A. Cucinotta et al., 2001), and
heart disease (National Council on Radiation Protection and Measurements, 2006) are also
of interest.
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In conclusion, the consistency with which we have demonstrated large losses in
bone at doses around 0.5 Gy are unprecedented and provide evidence that SPE are still
important in planning for crew safety during prolonged missions outside of low-earth orbit.
It now appears that the dose threshold for proton radiation is somewhere at or below 0.5
Gy and that there is a possible positive effect to cortical bone at these low doses. This has
significant implications for future space missions where whole body cumulative doses of
between 1 and 2 Gy can be delivered by a large SPE. Damage to bone following exposure
to mission-relevant doses of proton radiation presents a significant risk to astronauts on
long-term missions outside low-earth orbit. The current study demonstrates that even small
doses of protons are capable of negatively impacting bone and the effects are not mitigated
with decreased dose-rate.

4.5
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CHAPTER 5: LET EFFECT IN MURINE BONE AFTER EXPOSURE TO PROTONS
AND HEAVY IONS

5.1

Introduction

Astronauts on missions beyond low-earth orbit will be exposed to ionizing radiation
at levels greater than what is experienced on Earth outside of patients undergoing radiation
therapy. The negative effects of radiation on bone are well documented with exposure
leading to reductions in bone mass and strength. The corresponding increase in fracture
risk impacts the chance of mission success.
Solar radiation consists primarily of protons, helium nuclei, and high energy, high
charge (HZE) particles (nuclei of elements with Z>2) from two main sources: galactic
cosmic rays (GCR) and solar particle events (SPE). GCR provide a constant low fluence
of HZE ions while SPE add infrequent bursts of high-energy protons. HZE particles
represent only 1% of GCR flux (Simpson 1983), but account for 41% of the predicted dose
equivalent due to their high linear energy transfer (LET) (Cucinotta, Kim, and Chappell
2013) with iron (56Fe), silicon (28Si), oxygen (16O), and carbon (12C) being main
contributors. Current estimates place the overall duration of a mission to Mars at around
1000 days. During that time the tissue dose rates from GCR are estimated at about 0.4-0.8
mGy/day (National Council on Radiation Protection and Measurements 2000) with the
total dose received to be between 0.4 and 0.5 Gy (J. R. Williams et al. 1999; Cucinotta and
Durante 2006). This means every cell in the body will be traversed by a HZE particle every
few days (Cucinotta, Kim, and Chappell 2013).
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Altered biological effects have been associated with increasing LET, including a
differential response in cortical and trabecular bone. Following exposure to 2 Gy of
gamma, proton, carbon, or iron radiation, there was no difference in trabecular indices
(Hamilton et al. 2006), but the negative effects to cortical bone were greater for high-LET
(carbon and iron) exposures than low-LET (gamma and proton) exposures (S. A. J. Lloyd
et al. 2008). Previous data also suggests that low doses of radiation in a “mid-LET” range
may be more damaging to cortical bone than either of the previously examined LET levels
(Bandstra et al. 2009). However, there has been very little research directly comparing the
effects of low doses of radiation across a broad spectrum of LET.
While the majority of research regarding radiation-induced bone loss have utilized
doses in excess of what is estimated for long-term space travel (doses >1 Gy) (Hamilton et
al. 2006; S. A. J. Lloyd et al. 2008; Jeffrey S. Willey et al. 2010; Bandstra et al. 2008; S.
A. Lloyd et al. 2012), negative effects have also been demonstrated at lower doses. Both
trabecular and cortical bone were negatively impacted four months after exposure to 0.47
Gy mixed particle radiation simulating a GCR (Bandstra et al. 2009). Altered trabecular
microarchitecture was also observed three weeks after irradiation to 0.5 Gy with silicon
(Macias et al. 2016). Deterioration occurs rapidly with osteoclast numbers increasing as
early as three days after exposure (Jeffrey S. Willey et al. 2008) and significant loss of
trabecular bone within 1 week (Jeffrey S. Willey et al. 2010).
While the martian atmosphere or a heavily shielded spacecraft is thick enough (1020 g/cm2) to provide adequate shielding from most SPE (Ehresmann et al. 2016), shielding
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is impractical for protection against GCR (Wilson et al. 1997; Cucinotta, Kim, and Ren
2006); it would take hundreds of g/cm2 to sufficiently reduce organ doses (Cucinotta, Kim,
and Chappell 2013) and above 20 g/cm2 the dose equivalent actually increases due to
secondary particle generation (Slaba et al. 2017). This makes the development of
alternative countermeasures a high priority for future missions. A large part of any future
endeavor to create a successful radiation protection strategy will require a thorough
understanding of the biological effects of charged particles across the spectrum of LET.
The goal of this experiment was to examine the effects of modeled space radiation,
representing a range of LET, on the skeletal system of a mouse model. We hypothesized
that mid-LET ions would be energetic enough to kill bone cells (osteocytes being of
particular interest), and the greater flux (compared to high-LET ions) would kill a larger
number of osteocytes, thus initiating the bone resorption and removal process.

5.2

Materials & Methods

5.2.1 Animals
Female BALBc mice were purchased from Jackson Laboratories (Bar Harbor,
Maine) at 19 weeks of age, shipped directly from the vendor to the Brookhaven National
Laboratory (BNL), and allowed to acclimate for 1 week before study initiation. Mice were
maintained in a temperature-controlled (18-26°C) and light-controlled (12-hr light/dark
cycle) environment with food and water provided ad libitum. All experimental protocols
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were conducted with approval from the Institutional Animal Care and Use Committees of
BNL and the University of North Carolina at Chapel Hill (UNC).

5.2.2 Irradiation
Four groups (n = 24/ion) of mice received whole-body irradiation using protons
( H, 150 MeV/amu), linear energy transfer (LET) = 0.55 keV/µm, oxygen ( O, 600
1

16

MeV/amu), LET = 15 keV/µm, silicon ( Si, 600 MeV/amu), LET = 51 keV/µm, or iron
28

( Fe, 600 MeV/amu), LET = 181 keV/µm. Exposures were delivered at dose rates of 2056

50 cGy/min to total doses of 50 cGy for each ion. Due to logistical constraints, irradiations
for separate ions occurred over a period of several months. To account for differences
between animal batches, a group of non-irradiated controls was included for each ion (n =
24/ion).
Mice were placed individually into rectangular plastic aerated boxes (3 cm x 3 cm
x 8 cm). These boxes are routinely used for short-term restraint during irradiation, which
should require <10 minutes total handling time. Up to six unanesthetized animals at a time
were positioned inside the beam spot and irradiated. After exposures the animals were
returned to their original cages and transported back to the animal care facility. After 48
hours, the mice were transported by private courier to UNC for all biological examinations.
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5.2.3 End Point
All mice were humanely killed two weeks after irradiation. The right tibiae and
femurs were removed, cleaned of all non-osseous tissues, and placed in a solution of 10%
neutral buffered formalin. After 72 hours, the tibiae were rinsed with distilled water,
placed in 70% ethanol, and prepared for analysis using micro-computed tomography
(microCT).

5.2.4 Microcomputed Tomography
Sections of bone were scanned with microcomputed tomography (μCT80, Scanco
Medical AG, Bassersdorf, Switzerland) at an isotropic voxel size of 10 μm. Scanco
software (v. 6.1) was used to evaluate various markers of bone microarchitecture. Bone
morphometric properties were quantified on a 1 mm section (100 slices) immediately distal
to the growth plate in the proximal tibia as well as immediately proximal to the growth
plate in the distal femur. In addition, cortical parameters were also analyzed for 50 slices
at the mid-diaphysis femur. Trabecular bone parameters included: trabecular volume
fraction (BV/TV), connectivity density (Conn.D), trabecular thickness (Tb.Th), trabecular
number (Tb.N), trabecular separation (Tb.Sp), structure model index (SMI), and
volumetric bone mineral density (vBMD). vBMD is the total bone mineral content divided
by the total volume (TV) of the region of interest and is a good indicator of strength in
trabecular bone. BV/TV represents how much of TV is taken up by bone independent of
mineral density. Conn.D, Tb.Th, Tb.N, Tb.Sp, and SMI are all descriptors of trabecular

124

characteristics and indicators of bone quality. Analysis of cortical bone was conducted on
the cortical shell adjacent to the trabecular VOI and included: cortical porosity (Ct.Po),
cortical thickness (Ct.Th), volumetric bone mineral density (vBMD), tissue mineral density
(TMD), and polar moment of inertia (pMOI).

5.2.5 Finite Element Analysis
Trabecular bone strength was assessed through computational finite element
analysis (FEA) using Scanco’s built-in finite element solver. A 1 mm thick cross-section
of the proximal tibia was used with an axial compression to 5% deflection (0.05 mm). The
ability of the bone to resist displacement (stiffness, N/mm) was measured for all bones and
force to deflection (N) was calculated from stiffness*displacement.

5.2.6 Statistics
Data are presented as mean values +/- standard error. Statistical analyses were
performed using SigmaPlot 12 (Systat Software Inc., Richmond, CA). A paired t-test was
used to determine if mice gained or lost weight within an individual group during the period
of study. All other statistical comparisons used a standard t-test to determine significant
effects of radiation compared to non-irradiated controls. The threshold for significance for
all tests was set at a 5% probability of type I error (P=0.05).
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5.3

Results

5.3.1 Body Mass
Body masses were similar between control and irradiated animals for each radiation
group at study initiation (Table 5.1); however, silicon irradiated mice were significantly
smaller than control (4% smaller, P < 0.05) at time of death. Generally, body mass declined
(the oxygen group was the exception), but there was no difference in the amount of mass
lost between control and irradiated animals for any radiation group.

5.3.2 MicroCT Analysis of Trabecular Bone
Differences in various measures of trabecular microarchitecture were quantified
between irradiated and control groups in both the proximal tibial metaphysis and the distal
femur metaphysis (Figure 5.1 & Figure 5.2). Overall, mid-LET radiation types (silicon
and oxygen) were more likely to exhibit trabecular deterioration than high-LET (iron)
radiation while low-LET (protons) irradiation had no effect.
At the proximal tibia, mice irradiated with silicon had a 17% (P < 0.01) and 20%
(P < 0.01) decline in vBMD and BV/TV, respectively (Figure 5.1A, C). Likewise, Conn.D
(-22%, P < 0.05; Figure 5.2A), Tb.N (-7%, P < 0.05; Figure 5.2E), and Tb.Th (-4%, P <
0.05; Figure 5.2G) decreased while SMI (+11%, P < 0.05; Figure 5.2C) and Tb.Sp (+10%,
P < 0.05; Figure 5.2I) increased. Oxygen and iron irradiation resulted in more modest,
though still significant, declines in vBMD (O: -9%, P < 0.05; Fe: -11%, P < 0.05; Figure
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5.1C) and BV/TV (O: -11%, P < 0.05; Fe: -11%, P<0.05; Figure 5.1A) while SMI
increased significantly (O: +6%, P < 0.01; Fe: +8%, P < 0.01; Figure 5.1C). Conn.D was
also lower for iron (-14%, P < 0.05) but not oxygen irradiated mice (Figure 5.2A).
In the distal femur, silicon irradiated mice had lower vBMD (-29%, P < 0.001;
Figure 5.1D), BV/TV (-30%, P < 0.001; Figure 5.1B), Conn.D (-28%, P < 0.01; Figure
5.2B), Tb.N (-8%, P < 0.01; Figure 5.2F), Tb.Th (-7%, P < 0.05; Figure 5.2H), and
increased Tb.Sp (+10%, P < 0.01; Figure 5.2J) and SMI (26%, P < 0.001; Figure 5.2D)
compared with control. Oxygen again exhibited declines in vBMD (-20%, P < 0.01; Figure
5.1D) and BV/TV (-24%, P < 0.01; Figure 5.1B), and an increase in SMI (+15%, P < 0.01;
Figure 5.2D) with the addition of a -32% (P < 0.01; Figure 5.2B) and -5% (P < 0.05;
Figure 5.2H) decrease in Conn.D and Tb.Th, respectively. However, in contrast to the
proximal tibia, no difference was measured between iron irradiated and control mice for
any parameter besides Tb.Th (-5%, P < 0.05; Figure 5.2H).

5.3.3 MicroCT Analysis of Cortical Bone
Analysis of cortical bone revealed few significant differences relative to control,
but those differences that were detected appeared most often in a mid-LET radiation
(oxygen) (Table 5.2). The cortical bone at the proximal tibia was significantly thinner in
oxygen (-5%, P < 0.05), silicon (-6%, P < 0.01), and iron (-3%, P < 0.05) irradiated mice
compared with control (Figure 5.3B). Additionally, irradiation with oxygen lead to lower
porosity (-7%, P < 0.05; Figure 5.3A) and increased vBMD (+1%, P < 0.05; Figure 5.3C).

127

Porosity was also reduced at the distal femur only in oxygen irradiated mice (Table 5.3).
Cortical bone was unchanged at the mid-diaphysis of the femur for all radiation groups
(Table 5.4).

5.3.4 Analysis of Strength
At the proximal tibia, deflection force was reduced at all LET, but only silicon was
significantly so (Figure 5.4). Silicon irradiated mice required less force for whole bone (8.8%, P = 0.001; Figure 5.4A), cortical only (-8.1%, P < 0.01; Figure 5.4B), and trabecular
only analysis (-11.7%, P < 0.05, Figure 5.4C). Evaluation of the whole bone of oxygen
irradiated mice showed a trend to significance (-5.5%, P = 0.055; Figure 5.4B). The lower
strength was associated with a decrease in overall efficiency. Cortical bone was almost 5%
less efficient in both oxygen and silicon irradiated bones (Figure 5.5A). The trabecular
network was less efficient after irradiation (Figure 5.5B). Proton, oxygen, and iron all lost
around 8% efficiency, but only iron was statistically significant. Silicon irradiation resulted
in the most severe loss of efficiency (-15%, P < 0.01; Figure 5.5B).
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Table 5.1. Initial and Final Body Masses

Start Mass (g)
End Mass (g)
% Change

Proton
NR
IRR
26.7 ± 0.3
26.4 ± 0.4
26.0 ± 0.3
25.1 ± 0.4
-2.6*
-4.9*

Oxygen
NR
IRR
24.0 ± 0.3
23.8 ± 0.2
24.1 ± 0.2
24.2 ± 0.2
+0.4
+1.7

Silicon
NR
IRR
26.7 ± 0.3
26.2 ± 0.4
a
26.0 ± 0.3
24.9 ± 0.3a
*
-2.6
-5.0*

Iron
NR
IRR
27.8 ± 0.5
27.6 ± 0.4
27.3 ± 0.5
26.4 ± 0.4
-0.7
-3.0*

Notes. NR, Non-irradiated controls; IRR, Irradiated (50 cGy). Values are means ± SEM. * Significant change in mass for
a given group as determined by a paired t-test (P < 0.05). a Significant difference between NR and IRR groups within a given
type of radiation as determined by a standard t-test (P < 0.05).
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Figure 5.1: MicroCT trabecular parameters of the proximal tibia and distal femur. (A-B) volumetric bone mineral density,
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Figure 5.2: MicroCT trabecular parameters of the proximal
tibia and distal femur. (A-B) connectivity density, Conn.D,
(C-D) structural model index, SMI, (E-F) trabecular number,
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Table 5.2. Cortical properties as quantified by microCT within the proximal tibia.

Proton

NR
IRR

Ct.Po
%
9.1 ± 0.2
8.8 ± 0.2

Ct.Th
mm
213 ± 3
208 ± 3

pMOI
mm4
0.776 ± 0.022
0.784 ± 0.018

vBMD
mg HA/cm3
1013 ± 3
1012 ± 5

TMD
mg HA
1148 ± 3
1143 ± 4

Oxygen

NR
IRR

9.4 ± 0.2
8.7 ± 0.2*

191 ± 3
180 ± 3*

0.631 ± 0.014
0.633 ± 0.014

961 ± 4
971 ± 4*

1085 ± 4
1090 ± 4

Silicon

NR
IRR

9.1 ± 0.2
8.6 ± 0.2*

213 ± 3
199 ± 4*

0.776 ± 0.022
0.764 ± 0.017

1013 ± 3
1013 ± 4

1148 ± 3
1142 ± 4

Iron

NR
IRR

8.9 ± 0.2
8.5 ± 0.2

199 ± 3
192 ± 2*

0.749 ± 0.016
0.757 ± 0.016

997 ± 5
991 ± 4

1126 ± 5
1113 ± 5
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Notes. NR, Non-irradiated controls; IRR, Irradiated (50 cGy); Ct.Po, cortical porosity; Ct.Th, cortical
thickness; pMOI, polar moment of inertia; vBMD, volumetric bone mineral density; TMD, total mineral
density. All values are given as means ± SEM. *Significant difference compared to NR within a radiation
type (P < 0.05).

Table 5.3. Cortical properties as quantified by microCT within the distal femur.

Proton

NR
IRR

Ct.Po
%
2.7 ± 0.1
2.7 ± 0.1

Ct.Th
mm
196 ± 2
196 ± 2

pMOI
mm4
0.761 ± 0.013
0.771 ± 0.013

vBMD
mg HA/cm3
1025 ± 8
1018 ± 7

TMD
mg HA
1098 ± 10
1091 ± 7

Oxygen

NR
IRR

2.6 ± 0.1*
2.3 ± 0.1*

193 ± 2
188 ± 2

0.718 ± 0.013
0.690 ± 0.014

1001 ± 2
1002 ± 3

1079 ± 2
1076 ±3

Silicon

NR
IRR

2.7 ± 0.1
2.6 ± 0.1

196 ± 2
191 ± 2

0.761 ± 0.013
0.742 ± 0.015

1025 ± 8
1011 ± 5

1098 ± 10
1083 ± 5

Iron

NR
IRR

2.4 ± 0.1
2.3 ± 0.1

192 ± 2
189 ± 2

0.757 ± 0.017
0.755 ± 0.016

977 ± 3
981 ± 4

1045 ± 3
1049 ± 4
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Notes. NR, Non-irradiated controls; IRR, Irradiated (50 cGy); Ct.Po, cortical porosity; Ct.Th, cortical
thickness; pMOI, polar moment of inertia; vBMD, volumetric bone mineral density; TMD, total mineral
density. All values are given as means ± SEM. *Significant difference compared to NR within a radiation type
(P < 0.05).

Table 5.4. Cortical properties as quantified by microCT within the femur mid-shaft.

Proton

NR
IRR

Ct.Po
%
5.5 ± 0.4
5.8 ± 0.3

Ct.Th
mm
246 ± 2
245 ± 2

pMOI
mm4
0.331 ± 0.007
0.334 ± 0.006

vBMD
mg HA/cm3
1213 ± 9
1207 ± 9

TMD
mg HA
1233 ± 9
1227 ± 9

Oxygen

NR
IRR

6.0 ± 0.7
5.4 ± 0.7

210 ± 3
205 ± 2

0.283 ± 0.005
0.269 ± 0.006

1156 ± 3
1150 ± 2

1168 ± 4
1162 ± 2

Silicon

NR
IRR

5.5 ± 0.4
5.9 ± 0.6

246 ± 2
245 ± 2

0.331 ± 0.007
0.337 ± 0.007

1213 ± 9
1257 ± 9

1233 ± 9
1280 ± 9

Iron

NR
IRR

8.3 ± 0.9
8.6 ± 0.9

215 ± 2
213 ± 3

0.295 ± 0.007
0.287 ± 0.007

1131 ± 4
1129 ± 3

1142 ± 4
1141 ± 4
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Notes. NR, Non-irradiated controls; IRR, Irradiated (50 cGy); Ct.Po, cortical porosity; Ct.Th, cortical
thickness; pMOI, polar moment of inertia; vBMD, volumetric bone mineral density; TMD, total mineral
density. All values are given as means ± SEM. *Significant difference compared to NR within a radiation type
(P < 0.05).
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5.4

Discussion

Data in the present study suggest the negative effects of irradiation on both
trabecular and cortical bone are larger with exposure to mid-LET particles, particularly
silicon, relative to low- (protons) or high-LET (iron) particles. The effects of LET also
appear to be site specific. In trabecular bone, while there were significant declines in
trabecular microarchitecture with both mid- (oxygen and silicon) and high-LET (iron),
silicon consistently produced larger effects. For example, reduction in BV/TV in the
proximal tibia due to silicon was almost twice that of either oxygen or iron and almost three
times the effect of protons. In the distal femur, oxygen and silicon produced a much more
similar response (vBMD and BV/TV both declined by 20-30%), but both continued to
demonstrate a stronger negative response than the other ions. Cortical parameters were
largely spared from the effects of radiation exposure although there was some difference
based on the site examined. There was no change at the mid-diaphysis and distal femur,
but there was a potential LET effect at the proximal tibia with the strongest response again
in oxygen and silicon (mid-LET).
It was interesting to note that 0.5 Gy protons did not lead to significant declines in
trabecular bone or an anabolic response on the outer cortical (periosteal) surface as was
shown in the previous chapter. This difference is potentially due to the different mouse
strain used between the two studies. It is well established that there are distinct variations
in native bone parameters dependent on both genetic background and the specific site
examined within the skeleton (Judex, Garman, Squire, Donahue, et al. 2004; Judex,
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Garman, Squire, Busa, et al. 2004). We have already established that the mouse model for
radiation-induced bone loss was robust across mouse strains representing low (C57BL/6)
and high (DBA) endogenous bone mass. In the present study, we chose to challenge the
model again using a third strain of mouse. BALBc mice represent a medium BMD mouse
strain. The radiosensitivity of the bone marrow between the two strains is also very
different. Of the most commonly used mouse strains, B6 mice are the most resistant to
hematopoietic effects while BALBc are the most sensitive (J. P. Williams et al. 2010).
There was also a large variability in bone content between batches of mice. Due to
constraints on the availability of individual ion species, irradiations occurred over the
course of a couple of months. Multiple batches of mice were ordered from the same vendor
in order to ensure age-matching across all groups. The variable endogenous bone mass
presented one of the largest challenges of the study, making direct comparison between the
effects of different ion species difficult. Attempts at normalization based on mass or
pooling of the controls ultimately proved unsuccessful.
It should be noted that mice in the silicon group were the only ones to experience
significant loss of mass in response to irradiation. Effects to animal health have been
observed with high doses of radiation and associated with declined body mass (J. S. Willey
et al. 2008). However, at spaceflight relevant doses no changes to body mass have not been
previously noted (Bandstra et al. 2008, 2009). Lower body mass can affect skeletal loading
and alter bone strength. It would be irresponsible to completely discount the possibility that
the large effect of silicon irradiation on bone was at least partially due to a reduction in
body mass. However, proton irradiated animals lost a very similar amount of mass
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compared with silicon irradiated animals (4.9% and 5.0%, respectively; Table 5.1) but did
not see a significant decline in bone. From this, it is probably safe to assume that any effects
to bone due to change in mass are small.
Previously, we had demonstrated that whole-body exposure to multiple types of
radiation representing both low-LET (gamma and x-rays) and high-LET (carbon and iron)
caused profound loss of trabecular bone (Hamilton et al. 2006) and small changes to
cortical bone (S. A. J. Lloyd et al. 2008). LET effects were limited to cortical bone where
damage from high-LET was greater than low-LET (S. A. J. Lloyd et al. 2008). A following
study demonstrated that lower doses can in fact cause changes in bone although the exact
response appears to be different than that of higher doses. In response to a scattered dose
of 48 cGy of mixed-type radiation, both trabecular and cortical bone quality declined in the
proximal humerus (Bandstra et al. 2009). Cortical declines were noted as being much worse
than those seen at the 2 Gy dose used in the earlier study and it was proposed that this was
due to the mixed nature of the radiation. The base exposure was a collimated 2.4 Gy dose
of 1 GeV/amu 56Fe (LET = 151.4 keV/µm). Attenuation by the composite materials of the
collimator resulted in a gradient field of secondary radiation with a track average LET of
14.9 keV/µm. In the context of our previous findings, these results suggested that mid-LET
radiation may be more damaging to cortical bone than either the previously examined
carbon (LET = 13 keV/um) or iron ions (LET = 148 keV/um) (Bandstra et al. 2009).
It now appears LET effects may be dose dependent with some additional
mechanism present at higher doses that leads to additional bone loss. We have typically
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associated trabecular deterioration following irradiation with rapidly increased osteoclast
activity (Jeffrey S. Willey et al. 2008). It is believed that osteoclasts are stimulated by the
inflammatory microenvironment generated by damaged bone marrow cells. Marrow is
incredibly sensitive to radiation and even small doses can cause a large response. It is
known that exposure to radiation alters immune cell populations starting at doses of 0.5 Gy
(Pecaut et al. 2006) and, recently, the collapse of adult stem cell pools was shown to
precede deterioration of trabecular bone (Green et al. 2012). In light of the results of the
current study new questions have emerged. Is the inflammation-induced increase in
osteoclast activity masking a subtler effect to bone cells themselves? Additionally, could
this indicate that there are separate mechanisms behind deterioration of cortical and
trabecular bone?
Bone is a low cell density tissue with osteocytes, a fully differentiated, non-dividing
cell type, scattered sparsely throughout. Osteocyte apoptosis has been associated with the
initiation of bone resorption (Aguirre et al. 2006; Plotkin 2014; Kennedy et al. 2014) and
osteoclasts have been shown to engulf apoptotic osteocytes during remodeling (Cerri,
Boabaid, and Katchburian 2003). Radiation has been a known cause of osteocyte death
since the 1950s (Vaughan 1956), but has mostly been demonstrated in studies modeling
cancer treatment necessitating much higher doses than used in the present study (Rohrer,
Kim, and Fayos 1979; Maeda et al. 1988; Midgley et al. 1995). Although it was originally
associated with decreased vascularity at the irradiated site (Ham and Harris 1956), radiation
appears to affect osteocytes directly. Exposure to radiation increased expression of p53, a
key protein for apoptotic cell death (Midgley et al. 1995), and decreased osteocyte
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numbers, with a corresponding increase in empty lacunae, in a dose dependent fashion
(Tchanque-Fossuo et al. 2011).
Increasing LET is generally associated with worse outcomes for the same dose of
radiation in most tissues partially because the density of ionizations increases with LET.
This gives high-LET radiations a higher potential for biological effect because cell death
increases with LET (Jones, Dale, and Cárabe-Fernández 2009). Mid-LET radiation
represents a compromise between the high fluence of low-LET and the high cell-killing
power of high-LET. We originally hypothesized that this mix of particles energetic enough
to kill bone cells combined with a greater flux of ions would result in relatively more cell
killing and lead to greater bone loss.
For charged particles entering a macroscopic target, absorbed dose (D) is equal to
the number of particles traversing a unit area (fluence, ɸ) multiplied by LET and a constant
representing the spatial distribution of the particles (k):
𝐷 = Φ × 𝐿𝐸𝑇 × 𝑘
where k is equal to 1.602x10-7 for a 1 cm thickness of water (Nelson 2016). To achieve the
same dose across radiation types, increasing LET would be associated with decreasing
particle fluence. Relative to the present study, this means that fewer high-LET 600
MeV/amu iron ions (LET = 181 keV/µm) were needed to achieve the desired 0.5 Gy dose
compared with low-LET 150 MeV/amu protons (LET = 0.55 keV/µm). Taken together this
means more cells would be “hit” at low-LET, but the cellular damage would be lower and
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less likely to result in cell death. In contrast, high-LET results in more “un-hit” cells, but
any resulting damage would likely lead to apoptosis.
Traditionally, the effects of radiation on different tissues and cells are described in
terms of relative biological effectiveness (RBE), where RBE is the ratio of the dose of a
reference radiation to dose of test radiation that result in the same biological effect. The
most common reference radiation is either 250 kVp X-rays or 60Co 𝛾-rays (Nelson 2003).
However, RBE is based on the assumption of a uniform dose distribution and has been
most often used in a clinical setting where dose and particle fluence are high. In space, the
particle fluences relevant to GCR are in comparison very low. As a result, dose may not be
distributed as evenly across a tissue. In addition, it is no longer assumed that radiation
damage will only affect the directly irradiated cells. The introduction of “non-targeted”
effects (bystander effects) lead to a recognition that unirradiated cells and tissues could
develop a biological response due to the response of nearby irradiated tissues (Held 2009).
From the current data, it is unclear what the exact cellular response is or how many cells
are being affected.
In conclusion, this study demonstrates variable effects to cortical and
trabecular bone in response to radiation depending on LET. The results add new evidence
that the low doses and particle species astronauts would encounter during a Mars mission
cause sufficient deterioration of the skeletal system to lead to an increased risk of fracture.
This is particularly important when the additional skeletal insults of microgravity and
exposure to SPE are considered. While the exact mechanism is not clear it is possible that
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the bone loss is the result of altered function of osteocytes located within the bone matrix.
Further study would be needed to determine if this is true. Development of
countermeasures would be critical due to the inability of shielding to adequately counter
potential exposure.
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CHAPTER 6: CONCLUSIONS & RECOMMENDATIONS

6.1

Conclusions

The results presented in this dissertation support the hypothesis that spaceflightrelevant doses and types of radiation negatively impact bone. Similar to most research into
the effects of radiation, an animal model was used for these studies. Part of understanding
the mechanism behind radiation-induced bone loss is determining what parameters control
the model. Through several experiments the selected murine model was characterized and
found to be robust.
Bone loss and reduced bone strength are associated with increased fracture risk. On
an extended mission to the moon or Mars, any fracture would negatively impact the change
of mission success. While shielding and the protracted nature of SPE are assumed to
mitigate a large part of the risk of exposure to astronauts, calculations based on historical
data of large events still predict doses of 0.5 Gy are possible to the blood forming organs
(Hu et al. 2009).
This dissertation quantified trabecular deterioration with doses of proton below 1
Gy, which is currently believed to be the threshold for effects to bone and decreased doserate did not result in trabecular sparing. The level of bone deterioration was also affected
by the radiation’s LET. These findings findings add to the growing knowledge of the risks
involved in long-term exposure to the space environment outside of low-earth orbit. This
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knowledge will be critical in eventually developing countermeasures to mitigate the risk
and allow astronauts to safely achieve mission success.
Novel findings from this research include the following:

6.1.1 Chapter 3 Conclusions
● Trabecular deterioration was initiated with a 2 Gy dose of x-rays. This is in
agreement with findings showing doses of 2 Gy and below resulting in trabecular
bone loss (Hamilton et al. 2006; Bandstra et al. 2008, 2009; Kondo et al. 2009;
Willey et al. 2010). However, increasing the dose does not result in additional bone
loss and could indicate that there is a limit to how much bone can be lost.
● Bone loss occurs within two weeks with no major effects from animal strain, age,
or sex. This indicates that the model is robust and applicable to a more broad range
of conditions.
•

Effects in a directly irradiated site are similar whether irradiation occurs to only
part of the animal (locally) or the whole body (systemically) indicating that the
bone loss is not the result of exposure of other remote reactions to the radiation.

6.1.2 Chapter 4 Conclusions
● A 0.5 Gy dose of protons induces trabecular bone loss in mice. Damage worsens in
a linear fashion with increasing dose across the majority of parameters examined.
Previously the threshold for negative effects to trabecular bone was thought to be 1
Gy (Bandstra et al. 2008).
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● Anabolic bone formation occurs on the periosteal (outer) surface of cortical bone
two weeks after exposure to 0.5 Gy of protons, but not at higher doses. Previously,
no changes to cortical bone were observed for doses from 0.5-2 Gy of protons four
months after exposure (Bandstra et al. 2008).
● In trabecular bone, there is no sparing effect from decreased dose-rate compared to
acute exposure to a total dose of 2 Gy. Trabecular deterioration was similar for all
measured trabecular parameters.
● In cortical bone, there is inconsistent evidence of a sparing effect with decreasing
dose-rate compared with acute exposure to the same total dose. This study
demonstrates that dose-rate has an effect on the response of cortical bone to a 2 Gy
dose of protons, but whether the effect was positive or negative depended on which
parameter was evaluated.

6.1.3 Chapter 5 Conclusions
● Changes in trabecular parameters following irradiation to 0.5 Gy consistently
showed a linear energy transfer (LET) dependent effect with minor variations
depending on the site examined. At the proximal tibia, silicon (mid-LET) was
consistently more damaging than all other ions. At the distal femur, both oxygen
and silicon were more damaging than protons (low-LET) and iron (high-LET). No
LET effects were noted in trabecular bone in a previous comparison of gamma,
proton, carbon, and iron radiation where total dose was 2 Gy (Hamilton et al. 2006).
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● In cortical bone, it was confirmed that mid-LET radiation (oxygen and silicon)
causes greater effects than low-LET (protons) or high-LET (iron) radiation. The
hypothesis of mid-LET being more damaging is based on a previous observation
that 0.47 Gy dose of mid-LET mixed particle radiation caused greater cortical
deterioration than a 2 Gy dose of high-LET carbon or iron radiation (S. A. J. Lloyd
et al. 2008; Bandstra et al. 2009).
● Changes to cortical bone are site specific with effects at the proximal tibia, but not
at the distal or mid-shaft femur.
•

At the proximal tibia, declines in trabecular strength and efficiency were greatest
for mid-LET (silicon) radiation. There are similar trends in cortical strength and
efficiency and whole bone strength.

6.2

Recommendations

6.2.1 Understanding the anabolic effect to cortical bone with low dose protons
One of the well documented effects of radiation exposure at doses above 0.5 Gy is
the long-term suppression of bone formation by osteoblasts. However, the formation on
the outer surface of cortical bone observed in Chapter 4 raises new questions about the
response of osteoblasts to low doses (0.5 Gy) of radiation. Additional information from
histological and histomorphometric techniques will be needed to develop a full
understanding of the mechanisms behind this reaction. Serum markers may also provide
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some insight. It will also be important to determine if this effect is specific to the individual
strain of mouse used.

6.2.2 Combining low dose-rate and heavy ion exposure
Similar to SPE, exposure to GCR occurs at a very low dose-rate, on the order of a
few mGy/day, and even small doses are known to have profound negative effects in bone.
The results of Chapter 4 indicate dose-rate has no effect in trabecular bone and has a subtle
effect in cortical bone. However, the data represents only a single timepoint and the dose
used does not reflect current estimates for what an astronaut will most likely encounter.
Various iterations of future studies should look at lower doses and include additional types
of radiation including those composing GCR.

6.2.3 Evaluating cellular changes in response to modeled space radiation
Chapter 5 demonstrates that at the low doses expected during a Mars mission the
degree of bone loss depends on the LET of the radiation involved. It has been proposed
that this is due to increased killing of osteocytes leading to activation of bone resorption
via osteoclasts, but osteocyte survival or level of function was not evaluated. The
mechanism behind the effect will need to be better understood if countermeasures are to
be successfully developed. At higher doses, the mechanism behind bone loss is thought to
be inflammation in the marrow cavity leading to a rapid increase in osteoclast number and
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activity and bisphosphonates can successfully prevent bone loss in response to 2 Gy of xrays (Willey et al. 2010). Analysis of the blood serum and histological examinations at
earlier timepoints will us valuable tools to evaluate cellular activity levels at additional
earlier timepoints.

6.2.4 Modeling the spaceflight environment
One of the largest limitations of this dissertation is that it does not fully model the
complete environment that an astronaut will experience. Sources of risk include: unloading
due to microgravity, the constant background radiation from GCR, and random bursts of
SPE all present challenges to the skeletal system. Most research, including the studies
presented here, focus on only one or two aspects at a time. While this is important for
developing an understanding of the way bone reacts to individual stimuli, it will be equally
important to try various combinations to determine how they interact. Some studies have
already worked to combine unloading with radiation exposure (S. A. Lloyd et al. 2012),
but not at the low doses or using the protracted exposure times examined in in this
dissertation.
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